Fabrinet - Quarter Report: 2022 March (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________
FORM 10-Q
____________________________
(Mark One)
| ☒ | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
For the quarterly period ended March 25, 2022
OR
| ☐ | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | ||||
For the transition period from__________to__________
Commission File Number: 001-34775
____________________________
FABRINET
(Exact name of registrant as specified in its charter)
____________________________
Cayman Islands (State or other jurisdiction of incorporation or organization) | 98-1228572 (I.R.S. Employer Identification No.) | ||||
c/o Intertrust Corporate Services
One Nexus Way, Camana Bay
Grand Cayman
Cayman Islands
(Address of principal executive offices)
KY1-9005
(Zip Code)
+66 2-524-9600
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
| Ordinary Shares, $0.01 par value | FN | New York Stock Exchange | ||||||||||||
____________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”) during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days: Yes x No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | x | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | ☐ | ||||||||
| Emerging growth company | ☐ | ||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes x No
As of April 22, 2022, the registrant had 36,785,159 ordinary shares, $0.01 par value, outstanding.
1
FABRINET
FORM 10-Q
QUARTER ENDED MARCH 25, 2022
Table of Contents
| Page No. | |||||
2
RISK FACTORS SUMMARY
You should carefully consider the information set forth below under the heading “Risk Factors” in Part II, Item 1A before deciding whether to invest in our securities. Below is a summary of the principal risks associated with an investment in our securities.
•Our sales depend on a small number of customers. A reduction in orders from any of these customers, the loss of any of these customers, or a customer exerting significant pricing and margin pressures on us could harm our business, financial condition and operating results.
•Consolidation in the markets we serve could harm our business, financial condition and operating results.
•If the optical communications market does not expand as we expect, our business may not grow as fast as we expect.
•Our quarterly revenues, gross profit margins and operating results have fluctuated significantly and may continue to do so in the future, which may cause the market price of our ordinary shares to decline or be volatile.
•If we are unable to continue diversifying our precision optical and electro-mechanical manufacturing services across other markets within the optics industry, or if these markets do not grow as fast as we expect, our business may not grow as fast as we expect.
•If we are unable to compete successfully against our current and future competitors, our business, financial condition and operating results could be harmed.
•Cancellations, delays or reductions of customer orders and the relatively short-term nature of the commitments of our customers could harm our business, financial condition and operating results.
•Our exposure to financially troubled customers or suppliers could harm our business, financial condition and operating results.
•We purchase some of the critical materials used in certain of our products from a single source or a limited number of suppliers. Supply shortages have in the past, and could in the future, impair the quality, reduce the availability or increase the cost of materials, which could harm our revenues, profitability and customer relations.
•Managing our inventory is complex and may require write-downs due to excess or obsolete inventory, which could cause our operating results to decrease significantly in a given fiscal period.
•If we fail to adequately expand our manufacturing capacity, we will not be able to grow our business, which would harm our business, financial condition and operating results. Conversely, if we expand too much or too rapidly, we may experience excess capacity, which would harm our business, financial condition and operating results.
•We may experience manufacturing yields that are lower than expected, potentially resulting in increased costs, which could harm our business, operating results and customer relations.
•If the products that we manufacture contain defects, we could incur significant correction costs, demand for our services may decline and we may be exposed to product liability and product warranty claims, which could harm our business, financial condition, operating results and customer relations.
•If we fail to attract additional skilled employees or retain key personnel, our business, financial condition and operating results could suffer.
•We conduct operations in a number of countries, which creates logistical and communications challenges for us and exposes us to other risks and challenges that could harm our business, financial condition and operating results.
•We are subject to governmental export and import controls in several jurisdictions that subject us to a variety of risks, including liability, impairment of our ability to compete in international markets, and decreased sales and customer orders.
•We are subject to risks related to the ongoing U.S.-China trade dispute, including increased tariffs on materials that we use in manufacturing, which could adversely affect our business, financial condition and operating results.
•Fluctuations in foreign currency exchange rates and changes in governmental policies regarding foreign currencies could increase our operating costs, which would adversely affect our operating results.
•Political unrest and demonstrations, as well as changes in the political, social, business or economic conditions in Thailand, could harm our business, financial condition and operating results.
3
•We expect to continue to invest in our manufacturing operations in the People's Republic of China ("PRC"), which will continue to expose us to risks inherent in doing business in the PRC, any of which risks could harm our business, financial condition and operating results.
•Natural disasters, epidemics (including COVID-19), acts of terrorism and other political and economic developments could harm our business, financial condition and operating results.
•The loan agreements for our long-term debt obligations and other credit facilities contain financial ratio covenants that may impair our ability to conduct our business.
•The phase-out of the London Interbank Offered Rate ("LIBOR") could affect interest rates under our existing credit facility agreement, as well as our ability to seek future debt financing.
•Unfavorable worldwide economic conditions may negatively affect our business, financial condition and operating results.
•We may not be able to obtain capital when desired on favorable terms, if at all, or without dilution to our shareholders.
•Our investment portfolio may become impaired by deterioration of the capital markets.
•We are not fully insured against all potential losses. Natural disasters or other catastrophes could adversely affect our business, financial condition and operating results.
•There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with U.S. GAAP. Any changes in estimates, judgments and assumptions could have a material adverse effect on our business, financial condition and operating results.
•Our business and operations would be adversely impacted in the event of a failure of our information technology infrastructure and/or cyber security attacks.
•Intellectual property infringement claims against our customers or us could harm our business, financial condition and operating results.
•Any failure to protect our customers’ intellectual property that we use in the products we manufacture for them could harm our customer relationships and subject us to liability.
•We are subject to the risk of increased income taxes, which could harm our business, financial condition and operating results.
•We have incurred and will continue to incur significant increased costs as a result of operating as a public company, and our management will be required to continue to devote substantial time to various compliance initiatives.
•Failure to comply with applicable environmental laws and regulations could have a material adverse effect on our business, financial condition and operating results.
•If we are unable to meet regulatory quality standards applicable to our manufacturing and quality processes for the products we manufacture, our business, financial condition and operating results could be harmed.
•Our share price may be volatile due to fluctuations in our operating results and other factors, including the activities and operating results of our customers or competitors, any of which could cause our share price to decline.
•If securities or industry analysts do not publish research or if they publish misleading or unfavorable research about our business, the market price and trading volume of our ordinary shares could decline.
•We may become a passive foreign investment company, which could result in adverse U.S. tax consequences to U.S. investors.
•Our business and share price could be negatively affected as a result of activist shareholders.
•Certain provisions in our constitutional documents may discourage our acquisition by a third party, which could limit your opportunity to sell shares at a premium.
•Our shareholders may face difficulties in protecting their interests because we are incorporated under Cayman Islands law.
•Certain judgments obtained against us by our shareholders may not be enforceable.
•Energy price volatility may negatively impact our business, financial condition and operating results.
4
PART I: FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
FABRINET
CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)
| (in thousands of U.S. dollars, except share data and par value) | March 25, 2022 | June 25, 2021 | |||||||||
| Assets | |||||||||||
| Current assets | |||||||||||
| Cash and cash equivalents | $ | 269,140 | $ | 302,969 | |||||||
| Short-term investments | 245,852 | 244,963 | |||||||||
Trade accounts receivable, net of allowance for doubtful accounts of $61 and $100, respectively | 446,052 | 336,547 | |||||||||
| Contract assets | 13,568 | 11,878 | |||||||||
| Inventories | 452,638 | 422,133 | |||||||||
| Prepaid expenses | 13,729 | 11,398 | |||||||||
| Other current assets | 29,169 | 22,619 | |||||||||
| Total current assets | 1,470,148 | 1,352,507 | |||||||||
| Non-current assets | |||||||||||
| Long-term restricted cash | 157 | 154 | |||||||||
| Property, plant and equipment, net | 291,767 | 241,129 | |||||||||
| Intangibles, net | 3,593 | 4,371 | |||||||||
| Operating right-of-use assets | 4,790 | 6,699 | |||||||||
| Deferred tax assets | 9,171 | 9,428 | |||||||||
| Other non-current assets | 513 | 1,834 | |||||||||
| Total non-current assets | 309,991 | 263,615 | |||||||||
| Total Assets | $ | 1,780,139 | $ | 1,616,122 | |||||||
| Liabilities and Shareholders’ Equity | |||||||||||
| Current liabilities | |||||||||||
| Long-term borrowings, current portion, net | $ | 12,156 | $ | 12,156 | |||||||
| Trade accounts payable | 402,581 | 346,555 | |||||||||
| Fixed assets payable | 14,060 | 19,206 | |||||||||
| Contract liabilities | 1,923 | 1,680 | |||||||||
| Operating lease liabilities, current portion | 2,593 | 2,593 | |||||||||
| Income tax payable | 2,794 | 3,612 | |||||||||
| Accrued payroll, bonus and related expenses | 21,396 | 20,464 | |||||||||
| Accrued expenses | 21,144 | 17,134 | |||||||||
| Other payables | 24,012 | 20,958 | |||||||||
| Total current liabilities | 502,659 | 444,358 | |||||||||
| Non-current liabilities | |||||||||||
| Long-term borrowings, non-current portion, net | 18,241 | 27,358 | |||||||||
| Deferred tax liability | 5,771 | 5,107 | |||||||||
| Operating lease liability, non-current portion | 1,922 | 3,850 | |||||||||
| Severance liabilities | 20,352 | 19,485 | |||||||||
| Other non-current liabilities | 2,467 | 3,444 | |||||||||
| Total non-current liabilities | 48,753 | 59,244 | |||||||||
| Total Liabilities | 551,412 | 503,602 | |||||||||
| Commitments and contingencies (Note 15) | |||||||||||
| Shareholders’ equity | |||||||||||
Preferred shares (5,000,000 shares authorized, $0.01 par value; no shares issued and outstanding as of March 25, 2022 and June 25, 2021) | — | — | |||||||||
Ordinary shares (500,000,000 shares authorized, $0.01 par value; 39,039,725 shares and 38,749,045 shares issued at March 25, 2022 and June 25, 2021, respectively; and 36,780,528 shares and 36,765,456 shares outstanding at March 25, 2022 and June 25, 2021, respectively) | 390 | 388 | |||||||||
| Additional paid-in capital | 190,705 | 189,445 | |||||||||
Less: Treasury shares (2,259,197 shares and 1,983,589 shares as of March 25, 2022 and June 25, 2021, respectively) | (115,967) | (87,343) | |||||||||
| Accumulated other comprehensive income (loss) | (6,888) | (6,266) | |||||||||
| Retained earnings | 1,160,487 | 1,016,296 | |||||||||
| Total Shareholders’ Equity | 1,228,727 | 1,112,520 | |||||||||
| Total Liabilities and Shareholders’ Equity | $ | 1,780,139 | $ | 1,616,122 | |||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
FABRINET
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (unaudited)
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (in thousands of U.S. dollars, except per share data) | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | |||||||||||||||||||
| Revenues | $ | 564,395 | $ | 479,317 | $ | 1,674,350 | $ | 1,369,783 | |||||||||||||||
| Cost of revenues | (493,702) | (422,539) | (1,470,689) | (1,209,504) | |||||||||||||||||||
| Gross profit | 70,693 | 56,778 | 203,661 | 160,279 | |||||||||||||||||||
| Selling, general and administrative expenses | (17,034) | (19,059) | (55,412) | (53,078) | |||||||||||||||||||
| Expenses related to reduction in workforce | — | (43) | (135) | (43) | |||||||||||||||||||
| Operating income | 53,659 | 37,676 | 148,114 | 107,158 | |||||||||||||||||||
| Interest income | 414 | 941 | 1,470 | 3,156 | |||||||||||||||||||
| Interest expense | (73) | (282) | (347) | (798) | |||||||||||||||||||
| Foreign exchange gain (loss), net | (410) | 629 | 998 | 224 | |||||||||||||||||||
| Other income (expense), net | (36) | 124 | (1,351) | 403 | |||||||||||||||||||
| Income before income taxes | 53,554 | 39,088 | 148,884 | 110,143 | |||||||||||||||||||
| Income tax expense | (2,893) | (1,595) | (4,693) | (4,215) | |||||||||||||||||||
| Net income | 50,661 | 37,493 | 144,191 | 105,928 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||||||||||||||
| Change in net unrealized gain (loss) on available-for-sale securities | (2,455) | (570) | (3,615) | (937) | |||||||||||||||||||
| Change in net unrealized gain (loss) on derivative instruments | 666 | (5,000) | 2,743 | (5,823) | |||||||||||||||||||
| Change in net retirement benefits plan – prior service cost | 124 | 198 | 448 | 421 | |||||||||||||||||||
| Change in foreign currency translation adjustment | (34) | 90 | (198) | 547 | |||||||||||||||||||
| Total other comprehensive income (loss), net of tax | (1,699) | (5,282) | (622) | (5,792) | |||||||||||||||||||
| Net comprehensive income (loss) | $ | 48,962 | $ | 32,211 | $ | 143,569 | $ | 100,136 | |||||||||||||||
| Earnings per share | |||||||||||||||||||||||
| Basic | $ | 1.37 | $ | 1.02 | $ | 3.90 | $ | 2.87 | |||||||||||||||
| Diluted | $ | 1.35 | $ | 1.00 | $ | 3.85 | $ | 2.82 | |||||||||||||||
| Weighted-average number of ordinary shares outstanding (thousands of shares) | |||||||||||||||||||||||
| Basic | 36,940 | 36,875 | 36,945 | 36,876 | |||||||||||||||||||
| Diluted | 37,473 | 37,609 | 37,451 | 37,514 | |||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6
FABRINET
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (unaudited)
For the Three Months Ended March 25, 2022
| Ordinary Share | Additional Paid-in Capital | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Total | ||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||||||||
| Balances at December 24, 2021 | 39,008,996 | $ | 390 | $ | 185,940 | $ | (91,776) | $ | (5,189) | $ | 1,109,826 | $ | 1,199,191 | ||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | 50,661 | 50,661 | ||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — | — | (1,699) | — | (1,699) | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — | 5,723 | — | — | — | 5,723 | ||||||||||||||||||||||||||||||||||
| Issuance of ordinary shares | 30,729 | — | — | — | — | — | — | ||||||||||||||||||||||||||||||||||
Repurchase of 237,339 shares held as treasury shares | — | — | — | (24,191) | — | — | (24,191) | ||||||||||||||||||||||||||||||||||
| Tax withholdings related to net share settlement of restricted share units | — | — | (958) | — | — | — | (958) | ||||||||||||||||||||||||||||||||||
Balances at March 25, 2022 | 39,039,725 | $ | 390 | $ | 190,705 | $ | (115,967) | $ | (6,888) | $ | 1,160,487 | $ | 1,228,727 | ||||||||||||||||||||||||||||
For the Nine Months Ended March 25, 2022
| Ordinary Share | Additional Paid-in Capital | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Total | ||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||||||||
Balances at June 25, 2021 | 38,749,045 | $ | 388 | $ | 189,445 | $ | (87,343) | $ | (6,266) | $ | 1,016,296 | $ | 1,112,520 | ||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | 144,191 | 144,191 | ||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — | — | (622) | — | (622) | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — | 21,701 | — | — | — | 21,701 | ||||||||||||||||||||||||||||||||||
| Issuance of ordinary shares | 290,680 | 2 | (2) | — | — | — | — | ||||||||||||||||||||||||||||||||||
Repurchase of 275,608 shares held as treasury shares | — | — | — | (28,624) | — | — | (28,624) | ||||||||||||||||||||||||||||||||||
| Tax withholdings related to net share settlement of restricted share units | — | — | (20,439) | — | — | — | (20,439) | ||||||||||||||||||||||||||||||||||
Balances at March 25, 2022 | 39,039,725 | $ | 390 | $ | 190,705 | $ | (115,967) | $ | (6,888) | $ | 1,160,487 | $ | 1,228,727 | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
7
FABRINET
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY (unaudited) (Continued)
For the Three Months Ended March 26, 2021
| Ordinary Share | Additional Paid-in Capital | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Total | ||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||||||||
| Balances at December 25, 2020 | 38,698,068 | $ | 387 | $ | 177,125 | $ | (75,575) | $ | (1,657) | $ | 936,390 | $ | 1,036,670 | ||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | 37,493 | 37,493 | ||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — | — | (5,282) | — | (5,282) | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — | 6,864 | — | — | — | 6,864 | ||||||||||||||||||||||||||||||||||
| Issuance of ordinary shares | 43,098 | 1 | (1) | — | — | — | — | ||||||||||||||||||||||||||||||||||
Repurchase of 15,354 shares held as treasury shares | — | — | — | (1,238) | — | — | (1,238) | ||||||||||||||||||||||||||||||||||
| Tax withholdings related to net share settlement of restricted share units | — | — | (1,001) | — | — | — | (1,001) | ||||||||||||||||||||||||||||||||||
Balances at March 26, 2021 | 38,741,166 | $ | 388 | $ | 182,987 | $ | (76,813) | $ | (6,939) | $ | 973,883 | $ | 1,073,506 | ||||||||||||||||||||||||||||
For the Nine Months Ended March 26, 2021
| Ordinary Share | Additional Paid-in Capital | Treasury Shares | Accumulated Other Comprehensive Income (Loss) | Retained Earnings | Total | ||||||||||||||||||||||||||||||||||||
| (in thousands of U.S. dollars, except share data) | Shares | Amount | |||||||||||||||||||||||||||||||||||||||
| Balances at June 26, 2020 | 38,471,967 | $ | 385 | $ | 175,610 | $ | (68,501) | $ | (1,147) | $ | 868,062 | $ | 974,409 | ||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | 105,928 | 105,928 | ||||||||||||||||||||||||||||||||||
| Other comprehensive income (loss) | — | — | — | — | (5,792) | — | (5,792) | ||||||||||||||||||||||||||||||||||
Cumulative effect adjustment from adoption of | — | — | — | — | — | (107) | (107) | ||||||||||||||||||||||||||||||||||
| Share-based compensation | — | — | 18,742 | — | — | — | 18,742 | ||||||||||||||||||||||||||||||||||
| Issuance of ordinary shares | 269,199 | 3 | (3) | — | — | — | — | ||||||||||||||||||||||||||||||||||
Repurchase of 116,903 shares held as treasury shares | — | — | — | (8,312) | — | — | (8,312) | ||||||||||||||||||||||||||||||||||
| Tax withholdings related to net share settlement of restricted share units | — | — | (11,362) | — | — | — | (11,362) | ||||||||||||||||||||||||||||||||||
Balances at March 26, 2021 | 38,741,166 | $ | 388 | $ | 182,987 | $ | (76,813) | $ | (6,939) | $ | 973,883 | $ | 1,073,506 | ||||||||||||||||||||||||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
8
FABRINET
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
| Nine Months Ended | |||||||||||
| (in thousands of U.S. dollars) | March 25, 2022 | March 26, 2021 | |||||||||
| Cash flows from operating activities | |||||||||||
| Net income for the period | $ | 144,191 | $ | 105,928 | |||||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||||||||
| Depreciation and amortization | 28,907 | 26,781 | |||||||||
| Gain on disposal of property, plant and equipment | (175) | (24) | |||||||||
| Gain from sales and maturities of available-for-sale securities | (13) | (187) | |||||||||
| Amortization of investment discount | 3,038 | 1,479 | |||||||||
| Amortization of deferred debt issuance costs | 24 | 24 | |||||||||
| (Reversal of) allowance for doubtful accounts | (39) | (317) | |||||||||
| Unrealized gain on exchange rate and fair value of foreign currency forward contracts | (1,422) | (825) | |||||||||
| Amortization of fair value at hedge inception of interest rate swaps | (736) | (1,009) | |||||||||
| Share-based compensation | 21,701 | 18,742 | |||||||||
| Deferred income tax | 563 | (382) | |||||||||
| Other non-cash expenses | 1,067 | (614) | |||||||||
| Changes in operating assets and liabilities | |||||||||||
| Trade accounts receivable | (109,334) | (36,437) | |||||||||
| Contract assets | (1,690) | (3,874) | |||||||||
| Inventories | (30,503) | (43,497) | |||||||||
| Other current assets and non-current assets | (11,221) | (18,433) | |||||||||
| Trade accounts payable | 55,333 | 25,589 | |||||||||
| Contract liabilities | 243 | (147) | |||||||||
| Income tax payable | (872) | 911 | |||||||||
| Severance liabilities | 1,883 | 2,204 | |||||||||
| Other current liabilities and non-current liabilities | 6,952 | 3,404 | |||||||||
| Net cash provided by operating activities | 107,897 | 79,316 | |||||||||
| Cash flows from investing activities | |||||||||||
| Purchase of short-term investments | (119,853) | (183,041) | |||||||||
| Proceeds from sales of short-term investments | 19,463 | 84,049 | |||||||||
| Proceeds from maturities of short-term investments | 92,862 | 97,721 | |||||||||
| Purchase of property, plant and equipment | (75,327) | (33,269) | |||||||||
| Purchase of intangibles | (592) | (1,912) | |||||||||
| Proceeds from disposal of property, plant and equipment | 229 | 38 | |||||||||
| Net cash used in investing activities | (83,218) | (36,414) | |||||||||
| Cash flows from financing activities | |||||||||||
| Repayment of long-term borrowings | (9,141) | (9,141) | |||||||||
| Repayment of finance lease liability | — | (100) | |||||||||
| Repurchase of ordinary shares | (28,624) | (8,312) | |||||||||
| Withholding tax related to net share settlement of restricted share units | (20,439) | (11,362) | |||||||||
| Net cash used in financing activities | (58,204) | (28,915) | |||||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | $ | (33,525) | $ | 13,987 | |||||||
| Movement in cash, cash equivalents and restricted cash | |||||||||||
| Cash, cash equivalents and restricted cash at the beginning of period | $ | 303,123 | $ | 232,832 | |||||||
| Increase (decrease) in cash, cash equivalents and restricted cash | (33,525) | 13,987 | |||||||||
| Effect of exchange rate on cash, cash equivalents and restricted cash | (301) | 345 | |||||||||
| Cash, cash equivalents and restricted cash at the end of period | $ | 269,297 | $ | 247,164 | |||||||
| Non-cash investing and financing activities | |||||||||||
| Construction, software and equipment-related payables | $ | 14,060 | $ | 11,060 | |||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
9
FABRINET
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) (Continued)
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the same amounts shown in the unaudited condensed consolidated statements of cash flows:
| (amount in thousands) | As of March 25, 2022 | As of March 26, 2021 | |||||||||
| Cash and cash equivalents | $ | 269,140 | $ | 247,011 | |||||||
| Restricted cash | 157 | 153 | |||||||||
| Cash, cash equivalents and restricted cash | $ | 269,297 | $ | 247,164 | |||||||
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
10
FABRINET
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
(in thousands of U.S. dollars unless otherwise noted)
1. Business and organization
General
Fabrinet (“Fabrinet” or the “Parent Company”) was incorporated on August 12, 1999, and commenced operations on January 1, 2000. The Parent Company is an exempted company incorporated in the Cayman Islands, British West Indies. The “Company” refers to Fabrinet and its subsidiaries as a group.
The Company provides advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers (“OEMs”) of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices and sensors. The Company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly and testing. The Company focuses primarily on the production of low-volume, high-mix products. The principal subsidiaries of Fabrinet include Fabrinet Co., Ltd. (“Fabrinet Thailand”), Casix, Inc. (“Casix”), Fabrinet West, Inc. (“Fabrinet West”), Fabrinet UK Limited (“Fabrinet UK”) and Fabrinet Israel Ltd. (“Fabrinet Israel”).
2. Accounting policies
Basis of presentation
The accompanying unaudited condensed consolidated financial statements for Fabrinet as of March 25, 2022 and for the three and nine months ended March 25, 2022 and March 26, 2021 include normal recurring adjustments necessary for a fair statement of the financial statements set forth herein, in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such information does not include all of the information and footnotes required by U.S. GAAP for annual financial statements. For further information, please refer to the consolidated financial statements and footnotes thereto included in Fabrinet’s Annual Report on Form 10-K for the year ended June 25, 2021.
The balance sheet as of June 25, 2021 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements.
The results for the three and nine months ended March 25, 2022 may not be indicative of results for the year ending June 24, 2022 or any future periods.
Use of Estimates
The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the financial statements and the reported amount of total revenues and expenses during the year. The Company bases estimates on historical experience and various assumptions about the future that are believed to be reasonable based on available information. The Company’s reported financial position or results of operations may be materially different under different conditions or when using different estimates and assumptions, particularly with respect to significant accounting policies, which are discussed below. Significant assumptions are used in accounting for share-based compensation, allowance for doubtful accounts, allowance for expected credit losses, income taxes, inventory obsolescence, goodwill and valuation of intangible assets related to business acquisition, among others. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be different from these estimates. In the event that the Company's estimates or assumptions prove to be different from actual results, adjustments will be made in subsequent periods to reflect more current information. Additionally, the extent to which the evolving COVID-19 pandemic impacts the Company’s unaudited condensed consolidated financial statements will depend on a number of factors, including the magnitude and duration of the pandemic. These estimates may change as new events occur and additional information is obtained, as well as based upon the occurrence of other factors related to the COVID-19 pandemic that could result in material impacts to the Company's unaudited condensed consolidated financial statements in future reporting periods.
11
Fiscal years
The Company utilizes a 52-53 week fiscal year ending on the Friday in June closest to June 30. The three months ended March 25, 2022 and March 26, 2021 each consisted of 13 weeks. The nine months ended March 25, 2022 and March 26, 2021 each consisted of 39 weeks. Fiscal year 2022 will be comprised of 52 weeks and will end on June 24, 2022.
Adoption of New Accounting Standards
In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” The amendments in this update simplify the accounting for income taxes by removing certain exceptions to the general principles in Topic 740. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of Topic 740 by clarifying and amending existing guidance. The Company adopted this standard in the first quarter of fiscal year 2022 with no material impact on its unaudited condensed consolidated financial statements.
New Accounting Pronouncements – not yet adopted by the Company
In November 2021, FASB issued ASU 2021-10, “Government Assistance (Topic 832), Disclosures by Business Entities about Government Assistance,” which requires annual disclosures that increase the transparency of transactions involving government assistance, including (1) the types of transactions, (2) the accounting for those transactions, and (3) the effect of those transactions on an entity’s financial statements. The amendments in this update are effective for all entities within the ASU's scope for financial statements issued for annual periods beginning after December 15, 2021. This ASU will be effective for the Company in the first quarter of fiscal year 2023. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of this update on its consolidated financial statements.
12
3. Revenues from contracts with customers
Revenue by Geographic Area and End Market
Revenues are attributed to a particular geographic area based on the bill-to-location of the Company’s customers. The Company operates in three geographic regions: North America; Asia-Pacific and others; and Europe.
The following table presents total revenues by geographic region:
| (amount in thousands, except percentages) | Three Months Ended March 25, 2022 | As a % of Total Revenues | Nine Months Ended March 25, 2022 | As a % of Total Revenues | |||||||||||||||||||
| North America | |||||||||||||||||||||||
| U.S. | 292,475 | 781,469 | |||||||||||||||||||||
Others (1) | 4,123 | 8,996 | |||||||||||||||||||||
| Total revenue in North America | 296,598 | 52.5 | % | 790,465 | 47.2 | % | |||||||||||||||||
| Asia-Pacific and others | |||||||||||||||||||||||
| India | 70,956 | 210,009 | |||||||||||||||||||||
| Malaysia | 51,188 | 163,306 | |||||||||||||||||||||
| Hong Kong | 17,338 | 61,575 | |||||||||||||||||||||
| Israel | 16,883 | 67,318 | |||||||||||||||||||||
| Japan | 16,449 | 47,258 | |||||||||||||||||||||
| China | 12,843 | 40,624 | |||||||||||||||||||||
| Others | 10,559 | 34,349 | |||||||||||||||||||||
| Total revenue in Asia-Pacific and others | 196,216 | 34.8 | % | 624,439 | 37.3 | % | |||||||||||||||||
| Europe | |||||||||||||||||||||||
| Ireland | 28,640 | 133,024 | |||||||||||||||||||||
| U.K. | 21,632 | 64,151 | |||||||||||||||||||||
| Germany | 10,688 | 28,098 | |||||||||||||||||||||
| Others | 10,621 | 34,173 | |||||||||||||||||||||
| Total revenue in Europe | $ | 71,581 | 12.7 | % | $ | 259,446 | 15.5 | % | |||||||||||||||
| Total revenue | $ | 564,395 | 100.0 | % | $ | 1,674,350 | 100.0 | % | |||||||||||||||
13
| (amount in thousands, except percentages) | Three Months Ended March 26, 2021 | As a % of Total Revenues | Nine Months Ended March 26, 2021 | As a % of Total Revenues | |||||||||||||||||||
| North America | |||||||||||||||||||||||
| U.S. | 230,177 | 661,410 | |||||||||||||||||||||
Others (1) | 618 | 1,459 | |||||||||||||||||||||
| Total revenue in North America | 230,795 | 48.2 | % | 662,869 | 48.4 | % | |||||||||||||||||
| Asia-Pacific and others | |||||||||||||||||||||||
| Malaysia | 22,910 | 107,700 | |||||||||||||||||||||
| India | 56,719 | 85,535 | |||||||||||||||||||||
| Israel | 25,796 | 82,915 | |||||||||||||||||||||
| Hong Kong | 21,524 | 63,397 | |||||||||||||||||||||
| Japan | 18,582 | 56,223 | |||||||||||||||||||||
| Others | 21,770 | 71,477 | |||||||||||||||||||||
| Total revenue in Asia-Pacific and others | 167,301 | 34.9 | % | 467,247 | 34.1 | % | |||||||||||||||||
| Europe | |||||||||||||||||||||||
| Ireland | 47,096 | 149,696 | |||||||||||||||||||||
| U.K. | 15,298 | 40,742 | |||||||||||||||||||||
| Germany | 7,543 | 19,596 | |||||||||||||||||||||
| Others | 11,284 | 29,633 | |||||||||||||||||||||
| Total revenue in Europe | $ | 81,221 | 16.9 | % | $ | 239,667 | 17.5 | % | |||||||||||||||
| Total revenue | $ | 479,317 | 100.0 | % | $ | 1,369,783 | 100.0 | % | |||||||||||||||
(1)Others includes revenues from external customers based in our country of domicile, the Cayman Islands, which for each year presented is $0.
The following table presents revenues by end market:
| (amount in thousands, except percentages) | Three Months Ended March 25, 2022 | As a % of Total Revenues | Nine Months Ended March 25, 2022 | As a % of Total Revenues | |||||||||||||||||||
| Optical communications | $ | 440,003 | 78.0 | % | $ | 1,318,087 | 78.7 | % | |||||||||||||||
| Lasers, sensors and other | 124,392 | 22.0 | % | 356,263 | 21.3 | % | |||||||||||||||||
| Total | $ | 564,395 | 100.0 | % | $ | 1,674,350 | 100.0 | % | |||||||||||||||
| (amount in thousands, except percentages) | Three Months Ended March 26, 2021 | As a % of Total Revenues | Nine Months Ended March 26, 2021 | As a % of Total Revenues | |||||||||||||||||||
| Optical communications | $ | 361,739 | 75.5 | % | $ | 1,053,496 | 76.9 | % | |||||||||||||||
| Lasers, sensors and other | 117,578 | 24.5 | % | 316,287 | 23.1 | % | |||||||||||||||||
| Total | $ | 479,317 | 100.0 | % | $ | 1,369,783 | 100.0 | % | |||||||||||||||
14
Contract Assets and Liabilities
A contract asset is recognized when the Company has recognized revenues prior to generating an invoice for payment. Contract assets are classified separately within the unaudited condensed consolidated balance sheets and transferred to accounts receivable when rights to payment become unconditional.
A contract liability is recognized when the Company has advance payment arrangements with customers. The contract liabilities balance is normally recognized as revenue within six months.
The following tables summarize the activity in the Company’s contract assets and contract liabilities during the nine months ended March 25, 2022:
| (amount in thousands) | Contract Assets | ||||
Beginning balance, June 25, 2021 | $ | 11,878 | |||
| Revenue recognized | 37,195 | ||||
| Amounts collected or invoiced | (35,505) | ||||
Ending balance, March 25, 2022 | $ | 13,568 | |||
| (amount in thousands) | Contract Liabilities | ||||
Beginning balance, June 25, 2021 | $ | 1,680 | |||
| Advance payment received during the period | 4,898 | ||||
| Revenue recognized | (4,655) | ||||
Ending balance, March 25, 2022 | $ | 1,923 | |||
4. Earnings per ordinary share
Basic earnings per ordinary share is computed by dividing reported net income by the weighted-average number of ordinary shares outstanding during each period. Diluted earnings per ordinary share is computed by calculating the effect of potential dilutive ordinary shares outstanding during the period using the treasury stock method. Dilutive ordinary equivalent shares consist of restricted share units and performance share units.
Earnings per ordinary share was calculated as follows:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (amount in thousands except per share amounts) | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | |||||||||||||||||||
| Net income attributable to shareholders | $ | 50,661 | $ | 37,493 | $ | 144,191 | $ | 105,928 | |||||||||||||||
| Weighted-average number of ordinary shares outstanding (thousands of shares) | 36,940 | 36,875 | 36,945 | 36,876 | |||||||||||||||||||
Incremental shares arising from the assumed vesting of restricted share units and performance share units (thousands of shares) | 533 | 734 | 506 | 638 | |||||||||||||||||||
Weighted-average number of ordinary shares for diluted earnings per ordinary share (thousands of shares) | 37,473 | 37,609 | 37,451 | 37,514 | |||||||||||||||||||
| Basic earnings per ordinary share | $ | 1.37 | $ | 1.02 | $ | 3.90 | $ | 2.87 | |||||||||||||||
| Diluted earnings per ordinary share | $ | 1.35 | $ | 1.00 | $ | 3.85 | $ | 2.82 | |||||||||||||||
Outstanding performance share units excluded from the computation of diluted earnings per ordinary share (thousands of shares)(1) | — | 76 | — | 76 | |||||||||||||||||||
(1)These performance share units were not included in the computation of diluted earnings per ordinary share because they are not expected to vest based on the Company’s current assessment of the related performance obligations.
15
5. Cash, cash equivalents and short-term investments
The Company’s cash, cash equivalents, and short-term investments are as follows:
| Fair Value | |||||||||||||||||||||||||||||
| (amount in thousands) | Carrying Cost | Unrealized Gain/ (Loss) | Cash and Cash Equivalents | Marketable Securities | Other Investments | ||||||||||||||||||||||||
As of March 25, 2022 | |||||||||||||||||||||||||||||
| Cash | $ | 232,796 | $ | — | $ | 232,796 | $ | — | $ | — | |||||||||||||||||||
| Cash equivalents | 36,349 | (5) | 36,344 | — | — | ||||||||||||||||||||||||
| Liquidity funds | 31,382 | — | — | — | 31,382 | ||||||||||||||||||||||||
| Corporate debt securities | 192,746 | (3,024) | — | 189,722 | — | ||||||||||||||||||||||||
| U.S. agency and U.S. treasury securities | 25,024 | (276) | — | 24,748 | — | ||||||||||||||||||||||||
| Total | $ | 518,297 | $ | (3,305) | $ | 269,140 | $ | 214,470 | $ | 31,382 | |||||||||||||||||||
As of June 25, 2021 | |||||||||||||||||||||||||||||
| Cash | $ | 222,664 | $ | — | $ | 222,664 | $ | — | $ | — | |||||||||||||||||||
| Cash equivalents | 80,305 | — | 80,305 | — | — | ||||||||||||||||||||||||
| Liquidity funds | 30,000 | 1,226 | — | — | 31,226 | ||||||||||||||||||||||||
| Certificates of deposit and time deposits | 10,500 | — | — | — | 10,500 | ||||||||||||||||||||||||
| Corporate debt securities | 171,626 | 164 | — | 171,790 | — | ||||||||||||||||||||||||
| U.S. agency and U.S. treasury securities | 31,301 | 146 | — | 31,447 | — | ||||||||||||||||||||||||
| Total | $ | 546,396 | $ | 1,536 | $ | 302,969 | $ | 203,237 | $ | 41,726 | |||||||||||||||||||
All highly liquid investments with original maturities of three months or less at the date of purchase are classified as cash equivalents. Management determines the appropriate classification of its investments at the time of purchase and reevaluates the designations at each balance sheet date. The Company may sell certain of its short-term investments prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The maturities of the Company’s short-term investments generally range from three months to three years.
The following table summarizes the cost and estimated fair value of short-term investments classified as available-for-sale securities based on stated effective maturities as of March 25, 2022 and June 25, 2021:
| March 25, 2022 | June 25, 2021 | ||||||||||||||||||||||
| (amount in thousands) | Carrying Cost | Fair Value | Carrying Cost | Fair Value | |||||||||||||||||||
| Due within one year | $ | 68,455 | $ | 68,383 | $ | 30,000 | $ | 31,226 | |||||||||||||||
| Due between one to five years | 180,697 | 177,469 | 202,927 | 203,237 | |||||||||||||||||||
| Total | $ | 249,152 | $ | 245,852 | $ | 232,927 | $ | 234,463 | |||||||||||||||
As of March 25, 2022, the Company considered the decline in market value of its available-for-sale debt securities by using the AFS debt security impairment model. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. The Company assesses impairment at the individual security level according to applicable accounting standards by comparing fair value/market value with amortized cost. The Company considered factors such as the failure of the issuer of the security to make scheduled interest and principal payments and any changes to the credit rating of the security by a rating agency. The credit ratings of the Company's invested securities are still in compliance with the Company's investment policy. No impairment losses on available-for-sale debt securities were recorded for the three months ended March 25, 2022.
16
The following table summarizes the carrying cost of short-term investments classified as held-to-maturity securities based on stated effective maturities as of March 25, 2022 and June 25, 2021:
| (amount in thousands) | As of March 25, 2022 | As of June 25, 2021 | |||||||||
| Due within one year | $ | — | (1) | $ | 10,500 | ||||||
| Due between one to five years | — | — | |||||||||
| Total | $ | — | $ | 10,500 | |||||||
(1)Short-term investments classified as held-to-maturity securities as of June 25, 2021 matured in July 2021.
6. Fair value of financial instruments
Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy is established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs for the valuation of an asset or liability as of the measurement date. The three levels of inputs that may be used to measure fair value are defined as follows:
Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities.
Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for assets or liabilities, either directly or indirectly. If the assets or liabilities have a specified (contractual) term, Level 2 inputs must be observable for substantially the full term of assets or liabilities.
Level 3 inputs are unobservable inputs for assets or liabilities, which require the reporting entity to develop its own valuation techniques and assumptions.
The Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.
The following table provides details of the financial instruments measured at fair value on a recurring basis, including:
| Fair Value Measurements at Reporting Date Using | ||||||||||||||||||||||||||
| (amount in thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||
As of March 25, 2022 | ||||||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
| Cash equivalents | $ | — | $ | 36,344 | $ | — | $ | 36,344 | ||||||||||||||||||
| Liquidity funds | — | 31,382 | — | 31,382 | ||||||||||||||||||||||
| Corporate debt securities | — | 189,722 | — | 189,722 | ||||||||||||||||||||||
| U.S. agency and U.S. treasury securities | — | 24,748 | — | 24,748 | ||||||||||||||||||||||
| Derivative assets – current portion | — | 182 | (1) | — | 182 | |||||||||||||||||||||
| Total | $ | — | $ | 282,378 | $ | — | $ | 282,378 | ||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||
| Derivative liabilities – current portion | $ | — | $ | (2,834) | $ | — | $ | (2,834) | ||||||||||||||||||
| Derivative liabilities – non-current portion | — | (524) | — | (524) | ||||||||||||||||||||||
| Total | $ | — | $ | (3,358) | (2) | $ | — | $ | (3,358) | |||||||||||||||||
17
| Fair Value Measurements at Reporting Date Using | ||||||||||||||||||||||||||
| (amount in thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||
As of June 25, 2021 | ||||||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||||
| Cash equivalents | $ | — | $ | 80,305 | $ | — | $ | 80,305 | ||||||||||||||||||
| Liquidity funds | — | 31,226 | — | 31,226 | ||||||||||||||||||||||
| Corporate debt securities | — | 171,790 | — | 171,790 | ||||||||||||||||||||||
| U.S. agency and U.S. treasury securities | — | 31,447 | — | 31,447 | ||||||||||||||||||||||
| Derivative assets – current portion | — | 1 | (3) | — | 1 | |||||||||||||||||||||
| Total | $ | — | $ | 314,769 | $ | — | $ | 314,769 | ||||||||||||||||||
| Liabilities | ||||||||||||||||||||||||||
| Derivative liabilities – current portion | $ | — | $ | (5,654) | $ | — | $ | (5,654) | ||||||||||||||||||
| Derivative liabilities – non-current portion | — | (1,977) | — | (1,977) | ||||||||||||||||||||||
| Total | $ | — | $ | (7,631) | (4) | $ | — | $ | (7,631) | |||||||||||||||||
(1)Foreign currency forward contracts with a notional amount of $32.0 million and of 0.8 million Canadian dollars.
(2)Foreign currency forward contracts with a notional amount of $103.0 million and two interest rate swap agreements with an aggregate notional amount of $125.1 million.
(3)Foreign currency forward contracts with an aggregate notional amount of $2.0 million.
(4)Foreign currency forward contracts with an aggregate notional amount of $128.0 million and of 0.4 million Canadian dollars and two interest rate swap agreements with an aggregate notional amount of $125.1 million.
Derivative Financial Instruments
The Company utilizes derivative financial instruments to hedge (i) foreign exchange risk associated with certain foreign currency denominated assets and liabilities and other foreign currency transactions, and (ii) interest rate risk associated with its long-term debt.
The Company minimizes the credit risk associated with its derivative instruments by limiting the exposure to any single counterparty and by entering into derivative instruments only with counterparties that meet the Company’s minimum credit quality standard.
Foreign currency forward and option contracts
As a result of foreign currency rate fluctuations, the U.S. dollar equivalent values of the Company’s foreign currency denominated assets and liabilities fluctuate. The Company uses foreign currency forward and option contracts to manage the foreign exchange risk associated with a portion of its foreign currency denominated assets and liabilities and other foreign currency transactions. The Company enters into foreign currency forward and option contracts to hedge fluctuations in the U.S. dollar value of forecasted transactions denominated in Thai baht and Canadian dollars with counterparties that meet the Company’s minimum credit quality standard.
The Company may enter into foreign currency forward contracts with maturities of up to 12 months to hedge fluctuations in the U.S. dollar value of forecasted transactions denominated in Thai baht, including inventory purchases, payroll and other operating expenses. The Company considers these forward contracts as dual-purpose hedges, that hedge the foreign exchange fluctuation (i) from inception through the forecasted expenditure, and (ii) any subsequent revaluation of the account payable or accrual. The Company may designate the forward contracts that hedge the foreign exchange fluctuation from inception through the forecasted expenditure as cash flow hedges. The gain or loss on a derivative instrument designated and qualified as a cash flow hedging instrument is recorded as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. The reclassified amounts are presented in the same income statement line item as the earnings effect of the hedged item. Once the forecasted transactions are recorded, the Company will discontinue the hedging relationship by de-designating the derivative instrument and recording subsequent changes in fair value through contract maturity to foreign exchange gain (loss), net in the consolidated statements of operations and comprehensive income as a natural hedge against the Thai baht denominated assets and liabilities.
The Company may also enter into non-designated foreign currency forward and option contracts to provide an offset to the re-measurement of foreign currency denominated assets and liabilities and to hedge certain forecasted exposures.
18
Changes in the fair value of these non-designated derivatives are recorded as foreign exchange gain (loss), net in the consolidated statements of operations and comprehensive income.
As of March 25, 2022, the Company had 135 outstanding U.S. dollar foreign currency forward contracts against Thai baht, with an aggregate notional amount of $135.0 million and maturity dates ranging from April 2022 through October 2022 and one outstanding Canadian dollar foreign currency forward contract with an aggregate notional amount of 0.8 million Canadian dollars and a maturity date in June 2022.
As of June 25, 2021, the Company had 130 outstanding U.S. dollar foreign currency forward contracts against Thai baht with an aggregate notional amount of $130.0 million and maturity dates ranging from July 2021 through January 2022, and two foreign currency contracts with an aggregate notional amount of 0.4 million Canadian dollars and maturity dates in September 2021.
As of March 25, 2022, the hedging relationship over foreign currency forward contracts that were designated for hedge accounting was determined to be highly effective based on the performance of retrospective and prospective regression testing. As of March 25, 2022, the amount in accumulated other comprehensive income (“AOCI”) that is expected to be reclassified into earnings within 12 months was a loss of $1.1 million.
As of June 25, 2021, the hedging relationship over foreign currency forward contracts that were designated for hedge accounting was determined to be highly effective based on the performance of retrospective and prospective regression testing. As of June 25, 2021, the amount in AOCI that is expected to be reclassified into earnings within 12 months was a loss of $2.7 million.
During the three and nine months ended March 25, 2022, the Company recorded an unrealized gain of $0.1 million and $0.6 million, respectively, from changes in the fair value of a foreign currency forward contract that was not designated for hedge accounting, in earnings as foreign exchange gain (loss), net in the unaudited condensed consolidated statements of operations and comprehensive income.
During the three and nine months ended March 26, 2021, the Company recorded an unrealized loss of $2.0 million and $1.7 million, respectively, from changes in the fair value of a foreign currency forward contract that was not designated for hedge accounting, in earnings as foreign exchange gain (loss), net in the unaudited condensed consolidated statements of operations and comprehensive income.
Interest Rate Swap Agreements
The Company entered into interest rate swap agreements to mitigate interest rate risk and improve the interest rate profile of the Company’s debt obligations. As of March 25, 2022 and June 25, 2021, the Company had two outstanding interest rate swap agreements with an aggregate notional amount of $125.1 million.
On July 25, 2018, Fabrinet Thailand entered into an interest rate swap agreement to effectively convert the floating interest rate of its term loan under a credit facility agreement with Bank of America to a fixed interest rate of 2.86% per annum through the scheduled maturity of the term loan in June 2023 (see Note 10). The Company did not designate this interest rate swap for hedge accounting.
On September 3, 2019, the Company entered into a new term loan agreement under a credit facility agreement with the Bank of Ayudhya Public Company Limited (the “Bank”) (see Note 10) and on September 10, 2019, the Company repaid in full the outstanding term loan under the Bank of America credit facility agreement (see Note 10). In conjunction with the funding of the new term loan, the Company entered into a second interest rate swap agreement. The combination of both of these interest rate swaps effectively converts the floating interest rate of the Company’s new term loan with the Bank to a fixed interest rate of 4.36% per annum through the maturity of the term loan in June 2024.
On September 27, 2019, the Company designated these two interest rate swaps as a cash flow hedge for the Company’s term loan under the credit facility agreement with the Bank. The combination of these two interest rate swaps qualified for hedge accounting because the hedges are highly effective, and the Company has designated and documented contemporaneously the hedging relationships involving these interest rate swaps. While the Company intends to continue to meet the conditions for hedge accounting, if hedges do not qualify as highly effective, the changes in the fair value of the derivatives used as hedges would be reflected in earnings. From September 27, 2019, any gains or losses related to these interest rate swaps will be recorded in AOCI in the unaudited condensed consolidated balance sheets. The Company will reclassify a portion of the gains or losses from AOCI into earnings at each reporting period based on either the accrued interest amount or the interest payment.
19
As of March 25, 2022, the amount in AOCI that is expected to be reclassified into earnings within 12 months was a loss of $0.7 million.
As of June 25, 2021, the amount in AOCI that is expected to be reclassified into earnings within 12 months was a loss of $0.8 million.
The following table provides a summary of the impact of derivative gain (loss) of the Company’s foreign currency forward contracts and interest rate swaps which were designated as cash flow hedges on the unaudited condensed consolidated statements of operations and other comprehensive income:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||
| (amount in thousands) | Financial statements line item | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | ||||||||||||||||||||||||
| Derivatives gain (loss) recognized in other comprehensive income (loss): | |||||||||||||||||||||||||||||
| Foreign currency forward contracts | Other comprehensive income | $ | 1,009 | $ | (6,098) | $ | 2,558 | $ | (5,289) | ||||||||||||||||||||
| Interest rate swaps | Other comprehensive income | 882 | 453 | 1,885 | 1,196 | ||||||||||||||||||||||||
| Total derivatives gain (loss) recognized in other comprehensive income (loss) | $ | 1,891 | $ | (5,645) | $ | 4,443 | $ | (4,093) | |||||||||||||||||||||
Derivatives (gain) loss reclassified from accumulated other comprehensive income (loss) into earnings: | |||||||||||||||||||||||||||||
| Foreign currency forward contracts | Cost of revenues | $ | 1,117 | $ | (1,470) | $ | 6,216 | $ | (3,190) | ||||||||||||||||||||
| Foreign currency forward contracts | SG&A | 46 | (62) | 258 | (135) | ||||||||||||||||||||||||
| Foreign currency forward contracts | Foreign exchange loss, net | (2,165) | 2,491 | (7,438) | 2,604 | ||||||||||||||||||||||||
| Interest rate swaps | Interest expense | (223) | (314) | (736) | (1,009) | ||||||||||||||||||||||||
| Total derivatives (gain) loss reclassified from accumulated other comprehensive income (loss) into earnings | $ | (1,225) | $ | 645 | $ | (1,700) | $ | (1,730) | |||||||||||||||||||||
Change in net unrealized gain (loss) on derivatives instruments | $ | 666 | $ | (5,000) | $ | 2,743 | $ | (5,823) | |||||||||||||||||||||
Fair Value of derivatives
The following table provides the fair values of the Company’s derivative financial instruments for the periods presented:
| March 25, 2022 | June 25, 2021 | ||||||||||||||||||||||
| (amount in thousands) | Derivative Assets | Derivative Liabilities | Derivative Assets | Derivative Liabilities | |||||||||||||||||||
| Derivatives not designated as hedging instruments | |||||||||||||||||||||||
| Foreign currency forward and option contracts | $ | 19 | $ | (405) | $ | — | $ | (1,379) | |||||||||||||||
| Derivatives designated as hedging instruments | |||||||||||||||||||||||
| Foreign currency forward contracts | 163 | (1,289) | 1 | (2,703) | |||||||||||||||||||
| Interest rate swaps | — | (1,664) | — | (3,549) | |||||||||||||||||||
| Derivatives, gross balances | $ | 182 | $ | (3,358) | $ | 1 | $ | (7,631) | |||||||||||||||
20
The Company recorded the fair value of derivative financial instruments in the unaudited condensed consolidated balance sheets as follows:
| Derivative Financial Instruments | Balance Sheet line item | ||||
| Fair Value of Derivative Assets | Other current assets | ||||
| Fair Value of Derivative Liabilities | Accrued expenses | ||||
| Fair Value of Derivative Liabilities | Other non-current liabilities | ||||
7. Inventories
| (amount in thousands) | As of March 25, 2022 | As of June 25, 2021 | |||||||||
| Raw materials | $ | 181,160 | $ | 196,345 | |||||||
| Work in progress | 205,512 | 174,654 | |||||||||
| Finished goods | 16,969 | 15,471 | |||||||||
| Goods in transit | 48,997 | 35,663 | |||||||||
| Total inventories | $ | 452,638 | $ | 422,133 | |||||||
8. Leases
The Company leases facilities under non-cancelable operating lease agreements. The Company leases a portion of its capital equipment and vehicles, certain land and buildings for its facilities in Thailand, the Cayman Islands, the PRC, the U.S., the U.K., Israel and Singapore under operating lease arrangements that expire at various dates through 2025. Certain of these lease arrangements provide the Company the ability to extend the lease from to five years following the expiration of the current term. However, the Company has excluded all lease extension options from its right of use (“ROU”) assets and lease liabilities as the Company is not reasonably assured that it will exercise these options. None of the lease agreements contain residual value guarantees provided by the lessee. The Company also has one intercompany lease of office and manufacturing space.
Operating leases
As of March 25, 2022, the maturities of the Company’s operating lease liabilities were as follows:
| (amount in thousands) | ||||||||
| 2022 (remaining three months) | $ | 687 | ||||||
| 2023 | 2,675 | |||||||
| 2024 | 1,258 | |||||||
| 2025 | 41 | |||||||
| Total undiscounted lease payments | 4,661 | |||||||
| Less imputed interest | (146) | |||||||
| Total present value of lease liabilities | $ | 4,515 | (1) | |||||
(1)Included current portion of operating lease liabilities of $2.6 million.
Rental expense related to the Company’s operating leases is recognized on a straight-line basis over the lease term. Rental expense for long-term leases for the three and nine months ended March 25, 2022 was $0.7 million and $2.1 million, respectively, and for the three and nine months ended March 26, 2021 was $0.7 million and $1.9 million, respectively. Rental expense for short-term leases for the three and nine months ended March 25, 2022 was $0.1 million and $0.2 million, respectively, and for the three and nine months ended March 26, 2021 was $0.1 million and $0.3 million, respectively.
21
The following summarizes additional information related to the Company’s operating leases:
As of March 25, 2022 | As of June 25, 2021 | ||||||||||
| Weighted-average remaining lease term (in years) | 2.0 | 2.7 | |||||||||
| Weighted-average discount rate | 3.5 | % | 3.5 | % | |||||||
The following table presents supplemental disclosure for the unaudited condensed consolidated statement of cash flows related to operating and finance leases for the three and nine months ended March 25, 2022 and March 26, 2021:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (amount in thousands) | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | |||||||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities | |||||||||||||||||||||||
| Operating cash flows from operating leases | $ | 678 | $ | 628 | $ | 2,076 | $ | 1,889 | |||||||||||||||
| Financing cash flows from finance leases | $ | — | $ | — | $ | — | $ | 100 | |||||||||||||||
| ROU assets obtained in exchange for lease liabilities | $ | — | $ | 76 | $ | 38 | $ | 443 | |||||||||||||||
9. Intangibles
The following tables present details of the Company’s intangibles:
| (amount in thousands) | Gross Carrying Amount | Accumulated Amortization | Foreign Currency Translation Adjustment | Net | |||||||||||||||||||
| As of March 25, 2022 | |||||||||||||||||||||||
| Software | $ | 10,157 | $ | (7,417) | $ | — | $ | 2,740 | |||||||||||||||
| Customer relationships | 4,373 | (3,515) | (5) | 853 | |||||||||||||||||||
| Backlog | 119 | (119) | — | — | |||||||||||||||||||
| Total intangibles | $ | 14,649 | $ | (11,051) | $ | (5) | $ | 3,593 | |||||||||||||||
| (amount in thousands) | Gross Carrying Amount | Accumulated Amortization | Foreign Currency Translation Adjustment | Net | |||||||||||||||||||
As of June 25, 2021 | |||||||||||||||||||||||
| Software | $ | 9,767 | $ | (6,632) | $ | — | $ | 3,135 | |||||||||||||||
| Customer relationships | 4,373 | (3,195) | 58 | 1,236 | |||||||||||||||||||
| Backlog | 119 | (119) | — | — | |||||||||||||||||||
| Total intangibles | $ | 14,259 | $ | (9,946) | $ | 58 | $ | 4,371 | |||||||||||||||
The Company recorded amortization expense relating to intangibles of $0.4 million and $0.5 million for the three months ended March 25, 2022 and March 26, 2021, respectively, and $1.2 million for the nine months ended March 25, 2022 and March 26, 2021.
The weighted-average remaining life of customer relationships was:
| (years) | As of March 25, 2022 | As of June 25, 2021 | |||||||||
| Customer relationships | 3.3 | 3.9 | |||||||||
22
Based on the carrying amount of intangibles as of March 25, 2022, and assuming no future impairment of the underlying assets, the estimated future amortization during each fiscal year was as follows:
| (amount in thousands) | |||||
| 2022 (remaining three months) | $ | 509 | |||
| 2023 | 1,232 | ||||
| 2024 | 999 | ||||
| 2025 | 517 | ||||
| 2026 | 325 | ||||
| Thereafter | 11 | ||||
| Total | $ | 3,593 | |||
10. Borrowings
The Company’s total borrowings, including current and non-current portions of long-term borrowings, consisted of the following:
| (amount in thousands) | |||||||||||||||||||||||
| Rate | Conditions | Maturity | As of March 25, 2022 | As of June 25, 2021 | |||||||||||||||||||
| Long-term borrowings, current portion, net: | |||||||||||||||||||||||
| Long-term borrowings, current portion | $ | 12,188 | $ | 12,188 | |||||||||||||||||||
| Less: Unamortized debt issuance costs, current portion | (32) | (32) | |||||||||||||||||||||
| Long-term borrowings, current portion, net | $ | 12,156 | $ | 12,156 | |||||||||||||||||||
| Long-term borrowings, non-current portion, net: | |||||||||||||||||||||||
| Term loan borrowings: | |||||||||||||||||||||||
3-month LIBOR +1.35% per annum (1) | Repayable in quarterly installments | June 2024 | $ | 30,468 | $ | 39,609 | |||||||||||||||||
| Less: Current portion | (12,188) | (12,188) | |||||||||||||||||||||
| Less: Unamortized debt issuance costs, non-current portion | (39) | (63) | |||||||||||||||||||||
| Long-term borrowings, non-current portion, net | $ | 18,241 | $ | 27,358 | |||||||||||||||||||
(1)We have entered into interest rate swaps that effectively fix a series of our future interest payments on our term loans. Refer to Note 6.
The movements of long-term borrowings for the nine months ended March 25, 2022 and March 26, 2021 were as follows:
| Nine Months Ended | |||||||||||
| (amount in thousands) | March 25, 2022 | March 26, 2021 | |||||||||
| Opening balance | $ | 39,609 | $ | 51,797 | |||||||
| Borrowings during the period | — | — | |||||||||
| Repayments during the period | (9,141) | (9,141) | |||||||||
| Closing balance | $ | 30,468 | $ | 42,656 | |||||||
23
As of March 25, 2022, future maturities of long-term borrowings during each fiscal year were as follows:
| (amount in thousands) | |||||
| 2022 (remaining three months) | $ | 3,047 | |||
| 2023 | 15,233 | ||||
| 2024 | 9,141 | ||||
| 2025 | 3,047 | ||||
| Total | $ | 30,468 | |||
Credit facility agreements:
Bank of Ayudhya Public Company Limited
On August 20, 2019, Fabrinet Thailand (the “Borrower”) and Bank of Ayudhya Public Company Limited (the “Bank”) entered into a credit facility agreement (the “Credit Facility Agreement”), which provides for a facility of 110.0 million Thai baht (approximately $3.6 million based on the applicable exchange rate as of September 27, 2019) and $160.9 million that may be used for, among other things, an overdraft facility, short-term loans against promissory notes, a letter of guarantee facility, a term loan facility and foreign exchange facilities. The Bank may approve any request for extension of credit under the Credit Facility Agreement and may increase or decrease any facility amount in its sole discretion.
Under the Credit Facility Agreement, on August 20, 2019, the Borrower and the Bank entered into a term loan agreement (the "Term Loan Agreement") pursuant to which the Borrower drew down on September 3, 2019 a term loan in the original principal amount of $60.9 million. The proceeds from the term loan, together with cash on hand, were used to repay outstanding obligations under the Company’s previous syndicated senior credit facility agreement.
The term loan accrues interest at 3-month LIBOR plus 1.35% and is repayable in quarterly installments of $3.0 million, commencing on September 30, 2019. The term loan will mature on June 30, 2024. The Borrower may prepay the term loan in whole or in part at any time without premium or penalty. Any portion of the term loan repaid or prepaid may not be borrowed again. During the three and nine months ended March 25, 2022, the Company recorded $0.6 million and $1.7 million, respectively, of interest expense in connection with this term loan, including impact from interest rate swaps. $0.3 million and $0.6 million of these interest expenses were capitalized during the three and nine months ended March 25, 2022, respectively, in a new manufacturing building at the Company's Chonburi campus.
Any borrowings under the Credit Facility Agreement, including those borrowings under the Term Loan Agreement, are guaranteed by Fabrinet and secured by land and buildings owned by the Borrower in the Pathumthani and Chonburi Provinces in Thailand.
The Term Loan Agreement contains affirmative and negative covenants applicable to the Borrower, including delivery of financial statements and other information, compliance with laws, maintenance of insurance, restrictions on granting security interests or liens on its assets, disposing of its assets, incurring indebtedness and making acquisitions. While the term loan is outstanding, the Borrower is required to maintain a loan to value of the mortgaged real property ratio of not greater than 65%. If the loan to value ratio is not maintained, the Borrower will be required to provide additional security or prepay a portion of the term loan in order to restore the required ratio. The Company is also required to maintain a debt service coverage ratio of at least 1.25 times and a debt-to-equity ratio of less than or equal to 1.0 times. In the case of any payment of a dividend by the Company, its debt service coverage ratio must be at least 1.50 times. As of March 25, 2022, the Company was in compliance with all of its financial covenants under the Term Loan Agreement.
The events of default under the Term Loan Agreement include failure to timely pay amounts due under the Term Loan Agreement or the related finance documents, failure to comply with the covenants under the Term Loan Agreement or the related finance documents, cross default with other indebtedness of the Borrower, events of bankruptcy or insolvency in respect of the Borrower, and the occurrence of any event or series of events that in the opinion of the Bank has or is reasonably likely to have a material adverse effect.
As of March 25, 2022, there was $30.5 million outstanding under the term loan.
24
11. Income taxes
As of March 25, 2022 and June 25, 2021, the liability for uncertain tax positions including accrued interest and penalties was $1.5 million and $0.9 million, respectively. The Company expects the estimated amount of liability associated with its uncertain tax positions to increase within the next 12 months due to additional provisions on uncertain tax positions from one of its subsidiaries and interest on these positions.
The Company files income tax returns in the United States and foreign tax jurisdictions. The tax years from 2015 to 2021 remain open to examination by U.S. federal and state, and foreign tax authorities. The Company’s income tax is recognized based on the best estimate of the expected annual effective tax rate for the full financial year of each entity in the Company, adjusted for discrete items arising in that quarter. If the Company’s estimated annual effective tax rate changes, the Company makes a cumulative adjustment in that quarter.
The effective tax rate for the Company for the three months ended March 25, 2022 and March 26, 2021 was 5.4% and 4.1%, respectively, of net income. The increase was primarily due to the fact that the Company had more income subject to tax during the third quarter of fiscal year 2022 as compared to the same period in fiscal year 2021.
The effective tax rate for the Company for the nine months ended March 25, 2022 and March 26, 2021 was 3.2% and 3.8%, respectively, of net income. The decrease was primarily due to the fact that the Company had less income subject to tax during the first nine months of fiscal year 2022 as compared to the same period in fiscal year 2021.
12. Share-based compensation
Share-based compensation
The grant date fair value of restricted share units and performance share units is based on the market value of the Company's ordinary shares on the date of grant.
The effect of recording share-based compensation expense for the three and nine months ended March 25, 2022 and March 26, 2021 was as follows:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (amount in thousands) | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | |||||||||||||||||||
| Share-based compensation expense by type of award: | |||||||||||||||||||||||
| Restricted share units | $ | 3,126 | $ | 3,953 | $ | 11,720 | $ | 13,377 | |||||||||||||||
| Performance share units | 2,597 | 2,911 | 9,981 | 5,365 | |||||||||||||||||||
| Total share-based compensation expense | 5,723 | 6,864 | 21,701 | 18,742 | |||||||||||||||||||
| Tax effect on share-based compensation expense | — | — | — | — | |||||||||||||||||||
| Net effect on share-based compensation expense | $ | 5,723 | $ | 6,864 | $ | 21,701 | $ | 18,742 | |||||||||||||||
Share-based compensation expense was recorded in the unaudited condensed consolidated statements of operations and comprehensive income as follows:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (amount in thousands) | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | |||||||||||||||||||
| Cost of revenue | $ | 1,183 | $ | 1,388 | $ | 4,579 | $ | 4,805 | |||||||||||||||
| Selling, general and administrative expense | 4,540 | 5,476 | 17,122 | 13,937 | |||||||||||||||||||
| Total share-based compensation expense | $ | 5,723 | $ | 6,864 | $ | 21,701 | $ | 18,742 | |||||||||||||||
The Company did not capitalize any share-based compensation expense as part of any asset costs during the three and nine months ended March 25, 2022 and March 26, 2021.
25
Share-based award activity
On December 12, 2019, the Company’s shareholders approved Fabrinet’s 2020 Equity Incentive Plan (the “2020 Plan”). Upon the approval of the 2020 Plan, Fabrinet’s Amended and Restated 2010 Performance Incentive Plan (the “2010 Plan”) was simultaneously terminated. The 2020 Plan provides for the grant of equity awards thereunder with respect to (i) 1,700,000 ordinary shares, plus (ii) up to 1,300,000 ordinary shares that, as of immediately prior to the termination of the 2010 Plan, had been reserved but not issued pursuant to any awards granted under the 2010 Plan and are not subject to any awards thereunder. Upon termination of the 2010 Plan, 1,281,619 ordinary shares were reserved for issuance under the 2020 Plan pursuant to clause (ii) of the preceding sentence.
As of March 25, 2022, there were 299,009 restricted share units outstanding, 285,882 performance share units outstanding and 2,231,558 ordinary shares available for future grant under the 2020 Plan.
As of March 25, 2022, there were 149,755 restricted share units outstanding under the 2010 Plan. No ordinary shares are available for future grant under the 2010 Plan.
On November 2, 2017, the Company adopted the 2017 Inducement Equity Incentive Plan (the “2017 Inducement Plan”) with a reserve of 160,000 ordinary shares authorized for future issuance solely for the granting of inducement share options and equity awards to new employees. The 2017 Inducement Plan was adopted without shareholder approval in reliance on the “employment inducement exemption” provided under the New York Stock Exchange Listed Company Manual. As of March 25, 2022, there were 12,164 restricted share units outstanding and 111,347 ordinary shares available for future grant under the 2017 Inducement Plan.
The 2020 Plan, 2010 Plan and 2017 Inducement Plan are collectively referred to as the “Equity Incentive Plans.”
Restricted share units and performance share units
Restricted share units and performance share units have been granted under the Equity Incentive Plans.
Restricted share units granted to employees generally vest in equal installments over or four years on each anniversary of the vesting commencement date. Restricted share units granted to non-employee directors generally cliff vest 100% on the first of January, approximately one year from the grant date, provided the director continues to serve through such date.
Performance share units granted to executives will vest, if at all, at the end of a two-year performance period based on the Company’s achievement of pre-defined performance criteria, which consist of revenue and non-GAAP operating margin targets. The actual number of performance share units that may vest at the end of the performance period ranges from 0% to 100% of the award grant.
The following table summarizes restricted share unit activity under the Equity Incentive Plans:
| Number of Shares | Weighted- Average Grant Date Fair Value Per Share | ||||||||||
Balance as of June 25, 2021 | 641,875 | $ | 55.74 | ||||||||
| Granted | 165,684 | $ | 102.74 | ||||||||
| Issued | (310,473) | $ | 52.12 | ||||||||
| Forfeited | (36,158) | $ | 69.84 | ||||||||
Balance as of March 25, 2022 | 460,928 | $ | 73.96 | ||||||||
| Number of Shares | Weighted- Average Grant Date Fair Value Per Share | ||||||||||
| Balance as of June 26, 2020 | 797,757 | $ | 46.88 | ||||||||
| Granted | 222,886 | $ | 69.97 | ||||||||
| Issued | (347,662) | $ | 45.18 | ||||||||
| Forfeited | (23,432) | $ | 57.71 | ||||||||
Balance as of March 26, 2021 | 649,549 | $ | 55.33 | ||||||||
26
The following table summarizes performance share unit activity under the Equity Incentive Plans:
| Number of Shares | Weighted- Average Grant Date Fair Value Per Share | ||||||||||
Balance as of June 25, 2021 | 427,028 | $ | 57.82 | ||||||||
| Granted | 110,832 | $ | 101.05 | ||||||||
| Issued | (190,213) | $ | 48.65 | ||||||||
| Forfeited | (61,765) | $ | 53.38 | ||||||||
Balance as of March 25, 2022 | 285,882 | $ | 81.64 | ||||||||
| Number of Shares | Weighted- Average Grant Date Fair Value Per Share | ||||||||||
| Balance as of June 26, 2020 | 440,140 | $ | 48.37 | ||||||||
| Granted | 184,718 | $ | 69.85 | ||||||||
| Issued | (82,185) | 48.02 | |||||||||
| Forfeited | (115,645) | $ | 48.02 | ||||||||
Balance as of March 26, 2021 | 427,028 | $ | 57.82 | ||||||||
The fair value of restricted share units and performance share units is based on the market value of the Company's ordinary shares on the date of grant.
As of March 25, 2022, there was $13.6 million and $9.3 million of unrecognized share-based compensation expense related to restricted share units and performance share units, respectively, under the Equity Incentive Plans that is expected to be recorded over a weighted-average period of 2.4 and 1.1 years, respectively.
For the nine months ended March 25, 2022 and March 26, 2021, the Company withheld an aggregate of 210,006 shares and 160,648 shares, respectively, upon the vesting of restricted share units, based upon the closing share price on the vesting date to settle employee tax withholding obligations. For the nine months ended March 25, 2022 and March 26, 2021, the Company then remitted cash of $20.4 million and $11.4 million, respectively, to the appropriate taxing authorities and presented it as a financing activity within the unaudited condensed consolidated statements of cash flows. The payment was recorded as a reduction of additional paid-in capital.
13. Shareholders’ equity
Share capital
Fabrinet’s authorized share capital is 500,000,000 ordinary shares, par value of $0.01 per ordinary share, and 5,000,000 preferred shares, par value of $0.01 per preferred share.
For the three and nine months ended March 25, 2022, Fabrinet issued 30,729 and 290,680 ordinary shares, respectively, upon the vesting of restricted share units and performance share units under the Equity Incentive Plans, net of shares withheld.
For the three and nine months ended March 26, 2021, Fabrinet issued 43,098 and 269,199 ordinary shares, respectively, upon the vesting of restricted share units and performance share units under the Equity Incentive Plans, net of shares withheld.
All such issued shares are fully paid.
27
Treasury shares
In August 2017, the Company’s board of directors approved a share repurchase program to permit the Company to repurchase up to $30.0 million worth of its issued and outstanding ordinary shares in the open market in accordance with applicable rules and regulations. In February 2018, May 2019 and August 2020, the Company’s board of directors approved an increase of $30.0 million, $50.0 million and $58.5 million, respectively, to the original share repurchase authorization, bringing the aggregate authorization to $168.5 million. During the three and nine months ended March 25, 2022, the Company repurchased 237,339 and 275,608 shares, respectively, under the program at an average price per share (excluding other direct costs) of $101.90 and $103.84, respectively, totaling $24.2 million and $28.6 million, respectively. As of March 25, 2022, the Company had a remaining authorization to repurchase up to $52.5 million worth of its ordinary shares under the share repurchase program. Shares repurchased under the share repurchase program are held as treasury shares.
14. Accumulated other comprehensive income (loss)
The changes in AOCI for the nine months ended March 25, 2022 and March 26, 2021 were as follows:
| (amount in thousands) | Unrealized net (Losses)/Gains on Available-for-sale Securities | Unrealized net (Losses)/Gains on Derivative Instruments | Retirement benefit plan - Prior service cost | Foreign Currency Translation Adjustment | Total | ||||||||||||||||||||||||
Balance as of June 25, 2021 | $ | 308 | $ | (4,504) | $ | (1,425) | $ | (645) | $ | (6,266) | |||||||||||||||||||
| Other comprehensive income before reclassification adjustment | (3,602) | 4,443 | — | (198) | 643 | ||||||||||||||||||||||||
Amounts reclassified out of AOCI to the unaudited condensed consolidated statements of operations and comprehensive income | (13) | (1,700) | 448 | — | (1,265) | ||||||||||||||||||||||||
| Tax effects | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive income (loss) | $ | (3,615) | $ | 2,743 | $ | 448 | $ | (198) | $ | (622) | |||||||||||||||||||
Balance as of March 25, 2022 | $ | (3,307) | $ | (1,761) | $ | (977) | $ | (843) | $ | (6,888) | |||||||||||||||||||
| (amount in thousands) | Unrealized net (Losses)/Gains on Available-for-sale Securities | Unrealized net (Losses)/Gains on Derivative Instruments | Retirement benefit plan - Prior service cost | Foreign Currency Translation Adjustment | Total | ||||||||||||||||||||||||
| Balance as of June 26, 2020 | $ | 1,490 | $ | 602 | $ | (2,009) | $ | (1,230) | $ | (1,147) | |||||||||||||||||||
| Other comprehensive income before reclassification adjustment | (758) | (4,093) | — | 547 | (4,304) | ||||||||||||||||||||||||
Amounts reclassified out of AOCI to the unaudited condensed consolidated statements of operations and comprehensive income | (179) | (1,730) | 421 | — | (1,488) | ||||||||||||||||||||||||
| Tax effects | — | — | — | — | — | ||||||||||||||||||||||||
| Other comprehensive income (loss) | $ | (937) | $ | (5,823) | $ | 421 | $ | 547 | $ | (5,792) | |||||||||||||||||||
Balance as of March 26, 2021 | $ | 553 | $ | (5,221) | $ | (1,588) | $ | (683) | $ | (6,939) | |||||||||||||||||||
28
15. Commitments and contingencies
Bank guarantees
As of March 25, 2022 and June 25, 2021, there were outstanding bank guarantees on behalf of the Company's subsidiary in Thailand for electricity usage and other normal business expenses totaling to $1.5 million and $1.6 million, respectively, or Thai Baht 50.2 million. As of March 25, 2022 and June 25, 2021, the Company had an outstanding bank guarantee on behalf of its subsidiary in the PRC to support the subsidiary's operations totaling Renminbi 1.0 million, which bank guarantee was backed by cash collateral of $0.2 million. In addition, there were other immaterial bank guarantees on behalf of the Company's subsidiary in the U.K. to support its operations.
Purchase obligations
Purchase obligations represent legally binding commitments to purchase inventory and other commitments made in the normal course of business to meet operational requirements. Although open purchase orders are considered enforceable and legally binding, their terms generally give the Company the option to cancel, reschedule and/or adjust its requirements based on its business needs prior to the delivery of goods or performance of services. Obligations to purchase inventory and other commitments are generally expected to be fulfilled within one year.
As of March 25, 2022, the Company had a purchase obligation and other commitments to third parties of $1,414.6 million.
Capital expenditures
As of March 25, 2022, the Company had total capital expenditure commitments to third parties of $17.7 million.
Indemnification of directors and officers
Cayman Islands law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of directors and officers, except to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Fabrinet’s amended and restated memorandum and articles of association provide for indemnification of directors and officers for actions, costs, charges, losses, damages and expenses incurred in their capacities as such, except that such indemnification does not extend to any matter in respect of any fraud or dishonesty that may attach to any of them.
In accordance with Fabrinet’s form of indemnification agreement for its directors and officers, Fabrinet has agreed to indemnify its directors and officers against certain liabilities and expenses incurred by such persons in connection with claims by reason of their being such a director or officer. Fabrinet maintains a director and officer liability insurance policy that may enable it to recover a portion of any future amounts paid under the indemnification agreements.
16. Business segments and geographic information
29
Operating segments are defined as components of an enterprise for which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company’s chief operating decision maker is Fabrinet’s Chief Executive Officer. As of March 25, 2022, the Company operated and internally managed a single operating segment. Accordingly, the Company does not accumulate discrete information with respect to separate product lines and does not have separate reportable segments.
For the Company’s revenues by geographic region, see “Revenue by Geographic Area and End Market” in Note 3.
The following table presents long-lived assets by the country in which they are based:
| (amount in thousands) | March 25, 2022 | June 25, 2021 | ||||||||||||
| Long-Lived Assets: | ||||||||||||||
| Thailand | $ | 240,728 | $ | 190,843 | ||||||||||
| U.S. | 26,180 | 27,403 | ||||||||||||
| China | 18,444 | 14,977 | ||||||||||||
| Israel | 4,338 | 5,271 | ||||||||||||
| U.K. | 1,463 | 2,223 | ||||||||||||
| Cayman Island | 614 | 412 | ||||||||||||
| $ | 291,767 | $ | 241,129 | |||||||||||
Significant customers
The Company had two and three customers that each contributed to 10% or more of the Company's total trade accounts receivable as of March 25, 2022 and June 25, 2021, respectively.
30
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
In addition to historical information, this Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements relate to future events or to our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Forward-looking statements include, but are not limited to, statements about:
•our goals and strategies;
•our and our customers’ estimates regarding future revenues, operating results, expenses, capital requirements and liquidity;
•our belief that we will be able to maintain favorable pricing on our services;
•our expectation that the portion of our revenues attributable to customers in regions outside of North America for the remainder of fiscal year 2022 will be in line with the portion of those revenues for the nine months ended March 25, 2022;
•our expectation that we will incur incremental costs of revenue as a result of our planned expansion of our business into new geographic markets;
•our expectation that our fiscal year 2022 selling, general and administrative (“SG&A”) expenses will increase compared to fiscal year 2021 SG&A expenses;
•our expectation that our employee costs will increase in Thailand and the PRC;
•our future capital expenditures and our needs for additional financing;
•the expansion of our manufacturing capacity, including into new geographies;
•the growth rates of our existing markets and potential new markets;
•our ability, and the ability of our customers and suppliers, to respond successfully to technological or industry developments;
•our expectations regarding the potential impact of the COVID-19 pandemic on our business, financial condition and operating results;
•our suppliers’ estimates regarding future costs;
•our ability to increase our penetration of existing markets and to penetrate new markets;
•our plans to diversify our sources of revenues;
•our plans to execute acquisitions;
•trends in the optical communications, industrial lasers, and sensors markets, including trends to outsource the production of components used in those markets;
•our ability to attract and retain a qualified management team and other qualified personnel and advisors; and
•competition in our existing and new markets.
These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this Quarterly Report on Form10-Q, in particular, the risks discussed under the heading “Risk Factors” in Part II, Item 1A as well as those discussed in other documents we file with the Securities and Exchange Commission. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. “We,” “us” or “our” collectively refer to Fabrinet and its subsidiaries.
31
Overview
We provide advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers (“OEMs”) of complex products such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices and sensors. We offer a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly and testing. Although we focus primarily on low-volume production of a wide variety of high complexity products, which we refer to as “low-volume, high-mix,” we also have the capability to accommodate high-volume production. Based on our extensive experience, and the positive feedback we have received from our customers, we believe we are a global leader in providing these services to the optical communications, industrial lasers and automotive markets.
Our customer base includes companies in complex industries that require advanced precision manufacturing capabilities such as optical communications, industrial lasers, automotive and sensors. The products that we manufacture for our OEM customers include selective switching products; tunable transponders and transceivers; active optical cables; solid state, diode-pumped, gas and fiber lasers; and sensors. In many cases, we are the sole outsourced manufacturing partner used by our customers for the products that we manufacture for them.
We also design and fabricate application-specific crystals, lenses, prisms, mirrors, laser components, and substrates (collectively referred to as “customized optics”) and other custom and standard borosilicate, clear fused quartz, and synthetic fused silica glass products (collectively referred to as “customized glass”). We incorporate our customized optics and glass into many of the products we manufacture for our OEM customers, and we also sell customized optics and glass in the merchant market.
Recent Developments Related to COVID-19
The global COVID-19 pandemic has impacted us in several ways and created various challenges. At the onset of the pandemic, our PRC subsidiary, which manufactures custom optics components for us and other customers at its facility in Fuzhou, China, experienced a two-week temporary closure in January 2020 in accordance with the Chinese government’s official efforts to mitigate the spread of COVID-19. Furthermore, travel restrictions in the PRC during that period resulted in fewer than 90% of our employees in the PRC being able to return to work before early March 2020. Our other global manufacturing facilities also have been affected by government restrictions put in place to slow the spread of COVID-19. While our operations in Thailand have not been suspended, we have implemented a number of safety protocols to allow our operations in our facilities there to continue in accordance with government regulations. With the exception of our facility in Santa Clara, California, which closed for approximately one week beginning in late March 2020 before reopening in early April 2020 as a previously classified “essential business,” our facilities in the U.S., including in New Jersey, and in the U.K. have remained open while adhering to the local government restrictions.
During the three months ended March 25, 2022, several countries where we have manufacturing facilities, including Thailand, the PRC, the U.S. and the U.K., experienced a surge in the number of COVID-19 cases. We continue to take precautionary measures including implementing leaves of absence for affected employees and their close contacts, stringent contact tracing, enhanced safe distancing measures, and arrangements for the vaccination of our employees in Thailand. Although we did not experience any significant disruptions in our operations or decrease in customer demand during the three months ended March 25, 2022, any worsening of the pandemic may result in more stringent measures being implemented by local authorities, such as shutting down our manufacturing facilities, which would have a significant negative impact on our operations.
The health and well-being of our employees continues to be our top priority. In early 2020, we implemented significant precautionary measures throughout our worldwide operations to ensure our employees and their families remain safe. Such measures include mandatory temperature detection at building entrances, rigorous and regular facility and equipment disinfection, and mandatory personal protective equipment protocols, including (1) requiring the wearing of face masks throughout our factories at all times; (2) distributing our employees across shifts to better maintain safe personal distances; (3) isolating incoming parts and materials for a week or more prior to unpacking, or applying extreme heat to kill potential viruses; (4) directing our non-factory personnel to work remotely; and (5) restricting all non-employee visits to our campuses.
Given the unprecedented human and economic impact of the COVID-19 pandemic globally, the extraordinary economic short-term uncertainty resulting therefrom, and the evolving and differing national strategies for dealing with COVID-19, it is challenging to provide a forward-looking assessment. However, despite uncertainty and concern about the global economy and the health of various industries, we can share some relevant perspectives as we continue to assess the impacts of COVID-19 on our business in the future:
32
•With work-from-home protocols in place around the world, global demand for internet bandwidth has grown and we believe it will continue to grow. Because the next-generation telecom and datacom products we manufacture for our customers are important to expanding network capacity, we believe such growth in bandwidth demand will have a positive impact on our business in the long-term.
•While we believe the long-term growth outlook for the markets we serve has not been significantly impacted, in the short-term we are likely to continue to see regional downward demand adjustments, especially if the COVID-19 pandemic intensifies or returns in various geographic areas as was the case at the end of our third quarter in fiscal year 2020.
•In the near term, we expect to continue experiencing disruptions in our supply chain and fluctuations in the availability of parts and materials, especially if the COVID-19 pandemic intensifies or returns in various geographic areas. These disruptions and shortages have impacted, and will continue to impact, our ability to generate revenue.
•A significant portion of our costs is variable and, because of this, we can adjust manufacturing costs relatively quickly to respond to the changing demand of our customers. However, because parts and materials account for the largest portion of our costs, in combination with the supply chain issues noted above and, to a lesser extent, the expenses associated with the safety and health protocols we have implemented across our global operations, our gross margins will continue to be negatively affected for the foreseeable future.
•The safety and health of our employees is and will remain a key priority, and we will continue to follow robust safety protocols in all of our facilities. To this end, we arranged for the vaccination of our employees in Thailand in the first quarter of fiscal year 2022.
•Given our $515.0 million in cash, cash equivalents and short-term investments, and our total debt of approximately $30.5 million as of March 25, 2022, we believe we are in a solid position from a capital and financial resources perspective. We expect that our current cash and cash equivalent balances and short-term investments, and cash flows generated from operations will be sufficient to meet our domestic and international working capital needs and other capital and liquidity requirements for at least the next 12 months.
Revenues
We believe our ability to expand our relationships with existing customers and attract new customers is due to a number of factors, including our broad range of complex engineering and manufacturing service offerings, flexible low-cost manufacturing platform, process optimization capabilities, advanced supply chain management, excellent customer service, and experienced management team. Although we expect the prices we charge for our manufactured products to decrease over time (partly as a result of competitive market forces), we still believe we will be able to maintain favorable pricing for our services because of our ability to reduce cycle time, adjust our product mix by focusing on more complicated products, improve product quality and yields, and reduce material costs for the products we manufacture. We believe these capabilities have enabled us to help our OEM customers reduce their manufacturing costs while maintaining or improving the design, quality, reliability, and delivery times for their products.
We expect that disruptions in our supply chain and fluctuations in the availability of parts and materials will continue to have a significant impact on our ability to generate revenue, despite strong demand from our customers. These supply chain disruptions have been exacerbated by recent global events, such as (1) COVID-related lockdowns in China, which are causing freight and logistics issues and unforeseen delays, and (2) the armed conflict between Russia and Ukraine. While we have no direct business in Ukraine, the conflict has negatively impacted demand from some of our automotive customers that have other suppliers in the region. Moreover, if the facilities of our subsidiary in Fuzhou, China are locked down, we would also be negatively impacted since we and some of our customers rely on the optics components that are manufactured in such facilities. Furthermore, in some cases, our efforts to identify and secure alternative supply chain sources has resulted in our customers or their end customers requiring requalification and validation of components, a process that can often be lengthy and has negatively impacted the timing of our revenue. We expect these supply constraints to continue, and potentially worsen, for at least the next 12 months.
33
Revenues by Geography
We generate revenues from three geographic regions: North America; Asia-Pacific and others; and Europe. Revenues are attributed to a particular geographic area based on the bill-to location of our customers, notwithstanding that our customers may ultimately ship their products to end customers in a different geographic region. The majority of our revenues are derived from our manufacturing facilities in Asia-Pacific.
The percentage of our revenues generated from a bill-to location outside of North America decreased from 51.8% in the three months ended March 26, 2021 to 47.5% in the three months ended March 25, 2022, primarily because the increase in sales to our customers outside of North America was lower than the increase in sales to our customers in North America.
The percentage of our revenues generated from a bill-to location outside of North America increased from 51.6% in the nine months ended March 26, 2021 to 52.8% in the nine months ended March 25, 2022, primarily because the increase in sales to our customers outside of North America was greater than the increase in sales to our customers in North America.
Based on the short and medium-term indications and forecasts from our customers, we expect that the portion of our future revenues attributable to customers in regions outside North America for the remainder of fiscal year 2022 will be in line with the portion of revenues attributable to such customers during the nine months ended March 25, 2022.
The following table presents percentages of total revenues by geographic region:
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | ||||||||||||||||||||
| North America | 52.5 | % | 48.2 | % | 47.2 | % | 48.4 | % | |||||||||||||||
| Asia-Pacific and others | 34.8 | 34.9 | 37.3 | 34.1 | |||||||||||||||||||
| Europe | 12.7 | 16.9 | 15.5 | 17.5 | |||||||||||||||||||
| 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||||||||||
Our Contracts
We enter into supply agreements with our customers which generally have an initial term of up to three years, subject to automatic renewals for subsequent one-year terms unless expressly terminated. Although there are no minimum purchase requirements in our supply agreements, our customers provide us with rolling forecasts of their demand requirements. Our supply agreements generally include provisions for pricing and periodic review of pricing, consignment of our customer’s unique production equipment to us, and the sharing of benefits from cost-savings derived from our efforts. We are generally required to purchase materials, which may include long lead-time materials and materials that are subject to minimum order quantities and/or non-cancelable or non-returnable terms, to meet the stated demands of our customers. After procuring materials, we manufacture products for our customers based on purchase orders that contain terms regarding product quantities, delivery locations and delivery dates. Our customers generally are obligated to purchase finished goods that we have manufactured according to their demand requirements. Materials that are not consumed by our customers within a specified period of time, or are no longer required due to a product’s cancellation or end-of-life, are typically designated as excess or obsolete inventory under our contracts. Once materials are designated as either excess or obsolete inventory, our customers are typically required to purchase such inventory from us even if they have chosen to cancel production of the related products. The excess or obsolete inventory is shipped to the customer and revenue is recognized upon shipment.
Cost of Revenues
The key components of our cost of revenues are material costs, employee costs, and infrastructure-related costs. Material costs generally represent the majority of our cost of revenues. Several of the materials we require to manufacture products for our customers are customized for their products and often sourced from a single supplier or in some cases, our own subsidiaries. Shortages from sole-source suppliers due to yield loss, quality concerns and capacity constraints, among other factors, may increase our expenses and negatively impact our gross profit margin or total revenues in a given quarter. Material costs include scrap material. Historically, scrap rate diminishes during a product’s life cycle due to process, fixturing and test improvement and optimization.
A second significant element of our cost of revenues is employee costs, including indirect employee costs related to design, configuration and optimization of manufacturing processes for our customers, quality testing, materials testing and other
34
engineering services; and direct costs related to our manufacturing employees. Direct employee costs include employee salaries, insurance and benefits, merit-based bonuses, recruitment, training and retention. Historically, our employee costs have increased primarily due to increases in the number of employees necessary to support our growth and, to a lesser extent, costs to recruit, train and retain employees. Our cost of revenues is significantly impacted by salary levels in Thailand, the PRC and the U.K., the fluctuation of the Thai baht, Chinese Renminbi (“RMB”) and Pound Sterling (“GBP”) against our functional currency, the U.S. dollar, and our ability to retain our employees. We expect our employee costs to increase as wages continue to increase in Thailand and the PRC. Wage increases may impact our ability to sustain our competitive advantage and may reduce our profit margin. We seek to mitigate these cost increases through improvements in employee productivity, employee retention and asset utilization.
Our infrastructure costs are comprised of depreciation, utilities, facilities management and overhead costs. Most of our facility leases are long-term agreements. Our depreciation costs include buildings and fixed assets, primarily at our Pinehurst and Chonburi campuses in Thailand, and capital equipment located at each of our manufacturing locations.
We expect to incur incremental costs of revenue as a result of our planned expansion into new geographic markets, though we are not able to determine the amount of these incremental expenses.
Selling, General and Administrative Expenses
Our SG&A expenses primarily consist of corporate employee costs for sales and marketing, general and administrative and other support personnel, including research and development expenses related to the design of customized optics and glass, travel expenses, legal and other professional fees, share-based compensation expense and other general expenses not related to cost of revenues. In fiscal year 2022, we expect our SG&A expenses will increase as compared with our fiscal year 2021 SG&A expenses due to an increase in management compensation, staff cost, marketing and business development cost.
The compensation committee of our board of directors approved a fiscal year 2022 executive incentive plan with quantitative objectives that are based solely on achieving certain revenue targets and non-GAAP operating margin targets for our fiscal year ending June 24, 2022. Bonuses under the fiscal year 2022 executive incentive plan are payable after the end of fiscal year 2022. In fiscal year 2021, the compensation committee of our board of directors approved a fiscal year 2021 executive incentive plan with quantitative objectives based solely on achieving certain revenue targets and non-GAAP operating margin targets for fiscal year 2021.
Additional Financial Disclosures
Foreign Exchange
As a result of our international operations, we are exposed to foreign exchange risk arising from various currency exposures, primarily with respect to the Thai baht. Although a majority of our total revenues is denominated in U.S. dollars, a substantial portion of our payroll plus certain other operating expenses are incurred and paid in Thai baht. The exchange rate between the Thai baht and the U.S. dollar has fluctuated substantially in recent years and may continue to fluctuate substantially in the future. We report our financial results in U.S. dollars and our results of operations have been and could in the future be negatively impacted if the Thai baht appreciates against the U.S. dollar. Smaller portions of our expenses are incurred in a variety of other currencies, including RMB, GBP, Canadian dollars, Euros, and Japanese yen, the appreciation of which may also negatively impact our financial results.
In order to manage the risks arising from fluctuations in foreign currency exchange rates, we use derivative instruments. We may enter into exchange currency forward or put option contracts to manage foreign currency exposures associated with certain assets and liabilities and other forecasted foreign currency transactions and may designate these instruments as hedging instruments. The forward and put option contracts generally have maturities of up to 12 months. All foreign currency exchange contracts are recognized in the unaudited condensed consolidated balance sheets at fair value. Gains or losses on our forward and put option contracts generally present gross amount in the assets, liabilities, and transactions economically hedged.
We had foreign currency denominated assets and liabilities in Thai baht, RMB and GBP as follows:
35
As of March 25, 2022 | As of June 25, 2021 | ||||||||||||||||||||||||||||||||||
| (amount in thousands, except percentages) | Currency | $ | % | Currency | $ | % | |||||||||||||||||||||||||||||
| Assets | |||||||||||||||||||||||||||||||||||
| Thai baht | 727,851 | $ | 21,727 | 55.1 | % | 1,472,249 | $ | 46,312 | 67.5 | % | |||||||||||||||||||||||||
| RMB | 65,937 | 10,345 | 26.2 | 98,056 | 15,145 | 22.1 | |||||||||||||||||||||||||||||
| GBP | 5,589 | 7,381 | 18.7 | 5,111 | 7,119 | 10.4 | |||||||||||||||||||||||||||||
| Total | $ | 39,453 | 100.0 | % | $ | 68,576 | 100.0 | % | |||||||||||||||||||||||||||
| Liabilities | |||||||||||||||||||||||||||||||||||
| Thai baht | 2,549,770 | $ | 76,113 | 84.6 | % | 2,250,514 | $ | 70,793 | 87.7 | % | |||||||||||||||||||||||||
| RMB | 67,651 | 10,614 | 11.8 | 40,112 | 6,195 | 7.7 | |||||||||||||||||||||||||||||
| GBP | 2,428 | 3,207 | 3.6 | 2,656 | 3,699 | 4.6 | |||||||||||||||||||||||||||||
| Total | $ | 89,934 | 100.0 | % | $ | 80,687 | 100.0 | % | |||||||||||||||||||||||||||
The Thai baht assets represent cash and cash equivalents, trade accounts receivable, deposits and other current assets. The Thai baht liabilities represent trade accounts payable, accrued expenses, income tax payable and other payables. We manage our exposure to fluctuations in foreign exchange rates by the use of foreign currency contracts and offsetting assets and liabilities denominated in the same currency in accordance with management’s policy. As of March 25, 2022, there was $135.0 million of foreign currency forward contracts outstanding on the Thai baht payables. As of June 25, 2021, there was $130.0 million of foreign currency forward contracts outstanding on the Thai baht payables.
The RMB assets represent cash and cash equivalents, trade accounts receivable and other current assets. The RMB liabilities represent trade accounts payable, accrued expenses, income tax payable and other payables. As of March 25, 2022 and June 25, 2021, we did not have any derivative contracts denominated in RMB.
The GBP assets represent cash, trade accounts receivable, and other current assets. The GBP liabilities represent trade accounts payable and other payables. As of March 25, 2022 and June 25, 2021, we did not have any derivative contracts denominated in GBP.
For the three months ended March 25, 2022 and March 26, 2021, we recorded gain of $0.1 million and loss of $2.0 million, respectively, related to derivatives that are not designated as hedging instruments in the unaudited condensed consolidated statements of operations and comprehensive income.
For the nine months ended March 25, 2022 and March 26, 2021, we recorded gain of $0.6 million and loss of $1.7 million, respectively, related to derivatives that are not designated as hedging instruments in the unaudited condensed consolidated statements of operations and comprehensive income.
Currency Regulation and Dividend Distribution
Foreign exchange regulation in the PRC is primarily governed by the following rules:
•Foreign Currency Administration Rules, as amended on August 5, 2008 (the “Exchange Rules”);
•Administration Rules of the Settlement, Sale and Payment of Foreign Exchange (1996) (the “Administration Rules”); and
•Notice on Perfecting Practices Concerning Foreign Exchange Settlement Regarding the Capital Contribution by Foreign-invested Enterprises, as promulgated by the State Administration of Foreign Exchange (“SAFE”), on August 29, 2008 (“Circular 142”).
Under the Exchange Rules, RMB is freely convertible into foreign currencies for current account items, including the distribution of dividends, interest payments, trade and service-related foreign exchange transactions. However, conversion of RMB for capital account items, such as direct investments, loans, security investments and repatriation of investments, is still subject to the approval of SAFE.
Under the Administration Rules, foreign-invested enterprises may only buy, sell, or remit foreign currencies at banks authorized to conduct foreign exchange business after providing valid commercial documents and relevant supporting documents and, in the case of capital account item transactions, obtaining approval from SAFE. Capital investments by foreign-
36
invested enterprises outside of the PRC are also subject to limitations, which include approvals by the Ministry of Commerce, SAFE and the State Development and Reform Commission.
Circular 142 regulates the conversion by a foreign-invested company of foreign currency into RMB by restricting how the converted RMB may be used. Circular 142 requires that the registered capital of a foreign-invested enterprise settled in RMB converted from foreign currencies may only be used for purposes within the business scope approved by the applicable governmental authority and may not be used for equity investments within the PRC. In addition, SAFE strengthened its oversight of the flow and use of the registered capital of foreign-invested enterprises settled in RMB converted from foreign currencies. The use of such RMB capital may not be changed without SAFE’s approval and may not be used to repay RMB loans if the proceeds of such loans have not been used.
On January 5, 2007, SAFE promulgated the Detailed Rules for Implementing the Measures for the Administration on Individual Foreign Exchange (the “Implementation Rules”). Under the Implementation Rules, PRC citizens who are granted share options by an overseas publicly-listed company are required, through a PRC agent or PRC subsidiary of such overseas publicly-listed company, to register with SAFE and complete certain other procedures.
In addition, the General Administration of Taxation has issued circulars concerning employee share options. Under these circulars, our employees working in the PRC who exercise share options will be subject to PRC individual income tax. Our PRC subsidiary has obligations to file documents related to employee share options with relevant tax authorities and withhold individual income taxes of those employees who exercise their share options.
Furthermore, our transfer of funds to our subsidiaries in Thailand and the PRC are each subject to approval by governmental authorities in case of an increase in registered capital, or subject to registration with governmental authorities in case of a shareholder loan. These limitations on the flow of funds between our subsidiaries and us could restrict our ability to act in response to changing market conditions.
Income Tax
Our effective tax rate is a function of the mix of tax rates in the various jurisdictions in which we do business. We are domiciled in the Cayman Islands. Under the current laws of the Cayman Islands, we are not subject to tax in the Cayman Islands on income or capital gains until March 6, 2039.
Throughout the period of our operations in Thailand, we have generally received income tax and other incentives from the Thailand Board of Investment. Preferential tax treatment from the Thai government in the form of a corporate tax exemption on income generated from projects to manufacture certain products at our Chonburi campus is currently available to us through June 2026. Similar preferential tax treatment was available to us through June 2020 with respect to certain products manufactured at our Pinehurst campus Building 6. After June 2020, 50% of our income generated from certain products manufactured at our Pinehurst campus is exempted from tax through June 2025. Such preferential tax treatment is contingent on various factors, including the export of our customers’ products out of Thailand and our agreement not to move our manufacturing facilities out of our current province in Thailand for at least 15 years from the date on which preferential tax treatment was granted. Currently, the corporate income tax rate for our Thai subsidiary is 20%.
The corporate income tax rate for our subsidiaries in the PRC, the U.S., the U.K. and Israel are 25%, 21%, 19% and 23%, respectively.
Critical Accounting Policies and Use of Estimates
We prepare our unaudited condensed consolidated financial statements in conformity with U.S. GAAP, which requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities on the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the financial reporting period. We continually evaluate these estimates and assumptions based on the most recently available information, our own historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Because the use of estimates is an integral component of the financial reporting process, actual results could differ from those estimates. Some of our accounting policies require higher degrees of judgment than others in their application. We consider the policies discussed below to be critical to an understanding of our unaudited condensed consolidated financial statements, as their application places the most significant demands on our management’s judgment.
37
Our critical accounting policies are disclosed in our Annual Report on Form10-K for the fiscal year ended June 25, 2021. The adoption of new accounting policies and accounting standards are disclosed in Note 2 to the unaudited condensed consolidated financial statements. There were no changes to our accounting policies.
Results of Operations
The following table sets forth a summary of our unaudited condensed consolidated statements of operations and comprehensive income. Note that period-to-period comparisons of operating results should not be relied upon as indicative of future performance.
| (amount in thousands) | Three Months Ended | Nine Months Ended | |||||||||||||||||||||
| March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | ||||||||||||||||||||
| Revenues | $ | 564,395 | $ | 479,317 | $ | 1,674,350 | $ | 1,369,783 | |||||||||||||||
| Cost of revenues | (493,702) | (422,539) | (1,470,689) | (1,209,504) | |||||||||||||||||||
| Gross profit | 70,693 | 56,778 | 203,661 | 160,279 | |||||||||||||||||||
| Selling, general and administrative expenses | (17,034) | (19,059) | (55,412) | (53,078) | |||||||||||||||||||
| Expenses related to reduction in workforce | — | (43) | (135) | (43) | |||||||||||||||||||
| Operating income | 53,659 | 37,676 | 148,114 | 107,158 | |||||||||||||||||||
| Interest income | 414 | 941 | 1,470 | 3,156 | |||||||||||||||||||
| Interest expense | (73) | (282) | (347) | (798) | |||||||||||||||||||
| Foreign exchange gain (loss), net | (410) | 629 | 998 | 224 | |||||||||||||||||||
| Other income (expense), net | (36) | 124 | (1,351) | 403 | |||||||||||||||||||
| Income before income taxes | 53,554 | 39,088 | 148,884 | 110,143 | |||||||||||||||||||
| Income tax expense | (2,893) | (1,595) | (4,693) | (4,215) | |||||||||||||||||||
| Net income | 50,661 | 37,493 | 144,191 | 105,928 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax | (1,699) | (5,282) | (622) | (5,792) | |||||||||||||||||||
| Net comprehensive income | $ | 48,962 | $ | 32,211 | $ | 143,569 | $ | 100,136 | |||||||||||||||
The following table sets forth a summary of our unaudited condensed consolidated statements of operations and comprehensive income as a percentage of revenues for the periods indicated.
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | ||||||||||||||||||||
| Revenues | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
| Cost of revenues | (87.5) | (88.2) | (87.8) | (88.3) | |||||||||||||||||||
| Gross profit | 12.5 | 11.8 | 12.2 | 11.7 | |||||||||||||||||||
| Selling, general and administrative expenses | (3.0) | (4.0) | (3.4) | (3.9) | |||||||||||||||||||
| Expenses related to reduction in workforce | — | 0.0 | 0.0 | 0.0 | |||||||||||||||||||
| Operating income | 9.5 | 7.8 | 8.8 | 7.8 | |||||||||||||||||||
| Interest income | 0.1 | 0.2 | 0.1 | 0.2 | |||||||||||||||||||
| Interest expense | 0.0 | 0.0 | 0.1 | 0.0 | |||||||||||||||||||
| Foreign exchange gain (loss), net | (0.1) | 0.1 | 0.1 | 0.0 | |||||||||||||||||||
| Other income (expense), net | 0.0 | 0.0 | (0.2) | 0.0 | |||||||||||||||||||
| Income before income taxes | 9.5 | 8.1 | 8.9 | 8.0 | |||||||||||||||||||
| Income tax expense | (0.5) | (0.3) | (0.3) | (0.3) | |||||||||||||||||||
| Net income | 9.0 | 7.8 | 8.6 | 7.7 | |||||||||||||||||||
| Other comprehensive income (loss), net of tax | (0.3) | (1.1) | 0.0 | (0.4) | |||||||||||||||||||
| Net comprehensive income | 8.7 | % | 6.7 | % | 8.6 | % | 7.3 | % | |||||||||||||||
38
The following table sets forth our revenues by end market for the periods indicated.
| Three Months Ended | Nine Months Ended | ||||||||||||||||||||||
| (amount in thousands) | March 25, 2022 | March 26, 2021 | March 25, 2022 | March 26, 2021 | |||||||||||||||||||
| Optical communications | $ | 440,003 | $ | 361,739 | $ | 1,318,087 | $ | 1,053,496 | |||||||||||||||
| Lasers, sensors and other | 124,392 | 117,578 | 356,263 | 316,287 | |||||||||||||||||||
| Total | $ | 564,395 | $ | 479,317 | $ | 1,674,350 | $ | 1,369,783 | |||||||||||||||
We operate and internally manage a single operating segment. As such, discrete information with respect to separate product lines and segments is not accumulated.
Comparison of Three and Nine Months Ended March 25, 2022 with Three and Nine Months Ended March 26, 2021
Revenues
Our revenues increased by $85.1 million, or 17.7%, to $564.4 million for the three months ended March 25, 2022, compared with $479.3 million for the three months ended March 26, 2021. This increase was due to an increase in our key customers’ demand for optical communications manufacturing services during the three months ended March 25, 2022. Revenues from optical communications products increased by $78.3 million, or 21.6%, for the three months ended March 25, 2022 compared to the same period in the prior fiscal year.
Our revenues increased by $304.6 million, or 22.2%, to $1,674.4 million for the nine months ended March 25, 2022, compared with $1,369.8 million for the nine months ended March 26, 2021. This increase was due to an increase in our key customers’ demand for optical communications manufacturing services during the nine months ended March 25, 2022. Revenues from optical communications products increased by $264.6 million, or 25.1%, for the nine months ended March 25, 2022 compared to the same period in the prior fiscal year.
Cost of revenues
Our cost of revenues increased by $71.2 million, or 16.8%, to $493.7 million, or 87.5% of revenues, for the three months ended March 25, 2022, compared with $422.5 million, or 88.2% of revenues, for the three months ended March 26, 2021. This increase in cost of revenues on an absolute dollar basis was in line with the increase in sales volume.
Our cost of revenues increased by $261.2 million, or 21.6%, to $1,470.7 million, or 87.8% of revenues, for the nine months ended March 25, 2022, compared with $1,209.5 million, or 88.3% of revenues, for the nine months ended March 26, 2021. This increase in cost of revenues on an absolute dollar basis was in line with the increase in sales volume.
Gross profit
Our gross profit increased by $13.9 million, or 24.5%, to $70.7 million, or 12.5% of revenues, for the three months ended March 25, 2022, compared with $56.8 million, or 11.8% of revenues, for the three months ended March 26, 2021. The increase was primarily due to an increase in sales volume.
Our gross profit increased by $43.4 million, or 27.1%, to $203.7 million, or 12.2% of revenues, for the nine months ended March 25, 2022, compared with $160.3 million, or 11.7% of revenues, for the nine months ended March 26, 2021. The increase was primarily due to an increase in sales volume.
SG&A expenses
Our SG&A expenses decreased by $2.0 million, or 10.6%, to $17.0 million, or 3.0% of revenues, for the three months ended March 25, 2022, compared with $19.1 million, or 4.0% of revenues, for the three months ended March 26, 2021. The decrease was primarily due to (1) a decrease in share-based compensation expenses of $0.9 million, (2) a severance payment of $0.8 million related to a senior management retirement in the third quarter of fiscal year 2021, and (3) a decrease in start-up cost for our subsidiary in Israel of $0.4 million, offset by an increase in insurance expense of $0.1 million.
Our SG&A expenses increased by $2.3 million, or 4.4%, to $55.4 million, or 3.4% of revenues, for the nine months ended March 25, 2022, compared with $53.1 million, or 3.9% of revenues, for the nine months ended March 26, 2021. The increase was primarily due to (1) an increase in share-based compensation expenses of $3.2 million, mainly due to higher achievement of our targets for performance-based awards, (2) an increase in insurance expense of $0.5 million, and (3) the
39
reversal of allowance for doubtful debt of $0.3 million in the same period of fiscal year 2021, offset by a decrease in start-up cost for our subsidiary in Israel of $1.7 million.
Operating income
Our operating income increased by $16.0 million to $53.7 million, or 9.5% of revenues, for the three months ended March 25, 2022, compared with $37.7 million, or 7.8% of revenues, for the three months ended March 26, 2021. The increase was primarily due to an increase in revenues.
Our operating income increased by $41.0 million to $148.1 million, or 8.8% of revenues, for the nine months ended March 25, 2022, compared with $107.2 million, or 7.8% of revenues, for the nine months ended March 26, 2021. The increase was primarily due to an increase in revenues.
Interest income
Our interest income decreased by $0.5 million, or 56.0%, to $0.4 million, or 0.1% of revenues, for the three months ended March 25, 2022, compared with $0.9 million, or 0.2% of revenues, for the three months ended March 26, 2021. The decrease was primarily due to a lower weighted average interest rate during the three months ended March 25, 2022 compared to same period in the prior fiscal year.
Our interest income decreased by $1.7 million, or 53.4%, to $1.5 million, or 0.1% of revenues, for the nine months ended March 25, 2022, compared with $3.2 million, or 0.2% of revenues, for the nine months ended March 26, 2021. The decrease was primarily due to a lower weighted average interest rate during the nine months ended March 25, 2022 compared to same period in the prior fiscal year.
Interest expense
Our interest expense decreased by $0.2 million to $0.1 million for the three months ended March 25, 2022, compared with $0.3 million for the three months ended March 26, 2021. The decrease was primarily due to interest expense capitalized to a new manufacturing building at our Chonburi campus of $0.3 million during the three months ended March 25, 2022, offset by lower amortization of the fair value of interest rate swaps of $0.1 million.
Our interest expense decreased by $0.5 million to $0.3 million for the nine months ended March 25, 2022, compared with $0.8 million for the nine months ended March 26, 2021. The decrease was primarily due to interest expense capitalized to a new manufacturing building at our Chonburi campus of $0.6 million during the nine months ended March 25, 2022, offset by lower amortization of the fair value of interest rate swaps of $0.3 million.
Foreign exchange gain (loss), net
We recorded foreign exchange loss, net of $0.4 million for the three months ended March 25, 2022, compared with foreign exchange gain, net of $0.6 million for the three months ended March 26, 2021. The increase in foreign exchange loss was mainly due to (1) unrealized loss from revaluation of outstanding Thai baht assets and liabilities of $0.3 million for the three months ended March 25, 2022, as compared to unrealized gain from revaluation of outstanding Thai baht assets and liabilities of $2.5 million for the three months ended March 26, 2021, (2) foreign exchange loss from our subsidiaries in the PRC and the U.K. totaling $0.2 million for the three months ended March 25, 2022, as compared to foreign exchange gain from our subsidiaries in the PRC and the U.K. totaling $0.1 million for the three months ended March 26, 2021, and (3) lower unrealized gain from revaluation of other currencies of $8.0 thousand for the three months ended March 25, 2022, as compared to unrealized gain from revaluation of other currencies of $0.2 million for the three months ended March 26, 2021, offset by unrealized gain from mark-to-market forward contracts of $0.1 million for the three months ended March 25, 2022, as compared to unrealized loss from mark-to-market forward contracts of $2.0 million for the three months ended March 26, 2021.
We recorded foreign exchange gain, net of $1.0 million for the nine months ended March 25, 2022, compared with foreign exchange gain, net of $0.2 million for the nine months ended March 26, 2021. The increase in foreign exchange gain was mainly due to (1) unrealized gain from mark-to-market forward contracts of $0.6 million for the nine months ended March 25, 2022, as compared to unrealized loss from mark-to-market forward contracts of $1.7 million for the nine months ended March 26, 2021, and (2) realized gain from payment/receipt of $0.7 million for the nine months ended March 25, 2022, as compared to realized loss from payment/receipt of $1.1 million for the nine months ended March 26, 2021, partially offset by (1) foreign exchange loss from our subsidiaries in the PRC and the U.K. totaling $0.6 million for the nine months ended March 25, 2022, as compared to foreign exchange gain from our subsidiaries in the PRC and the U.K. totaling $1.2 million for the nine months ended March 26, 2021, and (2) lower unrealized gain from revaluation of outstanding Thai baht assets and
40
liabilities of $0.3 million for the nine months ended March 25, 2022, as compared to unrealized gain from revaluation of outstanding Thai baht assets and liabilities of $1.9 million for the nine months ended March 26, 2021.
Income before income taxes
We recorded income before income taxes of $53.6 million and $148.9 million for the three and nine months ended March 25, 2022, respectively, compared with $39.1 million and $110.1 million for the three and nine months ended March 26, 2021, respectively.
Income tax expense
Our provision for income tax reflects effective tax rates of 5.4% and 4.1% for the three months ended March 25, 2022 and March 26, 2021, respectively. The increase was primarily due to the fact that we had more income subject to tax during the third quarter of fiscal year 2022 as compared to the same period in fiscal year 2021.
Our provision for income tax reflects effective tax rates of 3.2% and 3.8% for the nine months ended March 25, 2022 and March 26, 2021, respectively. The decrease was primarily due to the fact that we had less income subject to tax during the first nine months of fiscal year 2022 as compared to the same period in fiscal year 2021.
Net income
We recorded net income of $50.7 million, or 9.0% of revenues, for the three months ended March 25, 2022, compared with $37.5 million, or 7.8% of revenues, for the three months ended March 26, 2021.
We recorded net income of $144.2 million, or 8.6% of revenues, for the nine months ended March 25, 2022, compared with $105.9 million, or 7.7% of revenues, for the nine months ended March 26, 2021.
Other comprehensive income (loss)
We recorded other comprehensive loss of $1.7 million, or 0.3% of revenues, for the three months ended March 25, 2022, compared with other comprehensive loss of $5.3 million, or 1.1% of revenues, for the three months ended March 26, 2021. The decrease in other comprehensive loss was mainly due to higher unrealized gain from mark-to-market of forward contracts and interest rate swap agreements of $0.7 million for the three months ended March 25, 2022, as compared to unrealized loss from mark-to-market of forward contracts and interest rate swap agreements of $5.0 million for the three months ended March 26, 2021, partially offset by (1) higher unrealized loss from mark-to-market of available-for-sale debt securities of $2.5 million for the three months ended March 25, 2022, as compared to unrealized loss from mark-to-market of available-for-sale debt securities of $0.6 million for the three months ended March 26, 2021, and (2) lower unrealized gain from foreign currency translation adjustment and retirement benefits plan of $0.1 million for the three months ended March 25, 2022, as compared to unrealized gain from foreign currency translation adjustment and retirement benefits plan of $0.3 million for the three months ended March 26, 2021.
We recorded other comprehensive loss of $0.6 million, or 0.0% of revenues, for the nine months ended March 25, 2022, compared with other comprehensive loss of $5.8 million, or 0.4% of revenues, for the nine months ended March 26, 2021. The decrease in other comprehensive loss was mainly due to unrealized gain from mark-to-market of forward contracts and interest rate swap agreements of $2.7 million for the nine months ended March 25, 2022, as compared to unrealized loss from mark-to-market of forward contracts and interest rate swap agreements of $5.8 million for the nine months ended March 26, 2021, partially offset by (1) higher unrealized loss from mark-to-market of available-for-sale debt securities of $3.6 million for the nine months ended March 25, 2022, as compared to unrealized loss from mark-to-market of available-for-sale debt securities of $0.9 million for the nine months ended March 26, 2021, and (2) unrealized loss from foreign currency translation adjustment of $0.2 million for the nine months ended March 25, 2022, as compared to unrealized gain from foreign currency translation adjustment of $0.5 million for the nine months ended March 26, 2021.
41
Liquidity and Capital Resources
Cash Flows and Working Capital
We primarily finance our operations through cash flow from operations. As of March 25, 2022 and March 26, 2021, we had cash, cash equivalents, and short-term investments of $515.0 million and $508.7 million, respectively, and outstanding debt of $30.5 million and $42.7 million, respectively.
Our cash and cash equivalents, which primarily consist of cash on hand, demand deposits, and liquid investments with original maturities of three months or less, are placed with banks and other financial institutions. The weighted-average interest rate on our cash and cash equivalents was 0.4% and 0.5% for the three and nine months ended March 25, 2022, respectively, and 0.7% and 0.8% for the three and nine months ended March 26, 2021, respectively.
Our cash investments are made in accordance with an investment policy approved by the audit committee of our board of directors. In general, our investment policy requires that securities purchased be rated A1, P-1, F1 or better. No security may have an effective maturity that exceeds three years. Our investments in fixed income securities are primarily classified as available-for-sale and are recorded at fair value. The cost of securities sold is based on the specific identification method. Unrealized gains and losses on these securities are recorded as other comprehensive income (loss) and are reported as a separate component of shareholders’ equity.
During the nine months ended March 25, 2022, we repaid $9.1 million of the term loan under our credit facility agreement with the Bank of Ayudhya Public Company Limited. As a result, as of March 25, 2022, we had a long-term borrowing of $30.5 million under such credit facility agreement. (See Note 10 for further details.) We anticipate that our internally generated working capital, along with our cash and cash equivalents will be adequate to repay these obligations. To better manage our cash on hand, we held short-term investments of $245.9 million as of March 25, 2022.
We believe that our current cash and cash equivalents, short-term investments, cash flow from operations, and funds available through our credit facility will be sufficient to meet our working capital and capital expenditure needs for at least the next 12 months. Our ability to sustain our working capital position is subject to a number of risks that we discuss in Part II, Item 1A of this Quarterly Report on Form 10-Q.
We also believe that our current manufacturing capacity is sufficient to meet our anticipated production requirements for at least the next few quarters.
The following table shows our cash flows for the periods indicated:
| Nine Months Ended | |||||||||||
| (amount in thousands) | March 25, 2022 | March 26, 2021 | |||||||||
| Net cash provided by operating activities | $ | 107,897 | $ | 79,316 | |||||||
| Net cash used in investing activities | $ | (83,218) | $ | (36,414) | |||||||
| Net cash used in financing activities | $ | (58,204) | $ | (28,915) | |||||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | $ | (33,525) | $ | 13,987 | |||||||
Operating Activities
Net cash provided by operating activities of $107.9 million for the nine months ended March 25, 2022 was primarily due to (1) net income of $144.2 million, (2) an increase in trade accounts payable of $55.3 million, (3) depreciation and amortization of $28.9 million, and (4) share-based compensation of $21.7 million; offset by (1) an increase in trade accounts receivable of $109.3 million, and (2) inventories of $30.5 million.
Net cash provided by operating activities of $79.3 million for the nine months ended March 26, 2021 was primarily due to (1) net income $105.9 million, (2) an increase in depreciation and amortization of $26.8 million, (3) trade accounts payable $25.6 million, and (4) share-based compensation of $18.7 million; offset by (1) an increase in inventories of $43.5 million, (2) trade accounts receivable of $36.4 million, and (3) other assets of $18.4 million.
42
Investing Activities
Net cash used in investing activities of $83.2 million for the nine months ended March 25, 2022 was primarily due to (1) the purchase of property, plant and equipment of $75.3 million, mainly related to investment in a new manufacturing building at our Chonburi campus, acquisition of land and other equipments, (2) a net purchase of short-term investments of $7.5 million, and (3) the purchase of intangibles assets of $0.6 million.
Net cash used in investing activities of $36.4 million for the nine months ended March 26, 2021 was primarily due to (1) the purchase of property, plant and equipment of $33.3 million, (2) the purchase of intangibles assets of $1.9 million, and (3) a net purchase of short-term investments of $1.3 million.
Financing Activities
Net cash used in financing activities of $58.2 million for the nine months ended March 25, 2022 was primarily due to (1) cash paid for repurchase of ordinary shares of $28.6 million, (2) withholding tax related to net share settlement of restricted share units of $20.4 million, and (3) repayment of bank loans of $9.1 million.
Net cash used in financing activities of $28.9 million for the nine months ended March 26, 2021 was primarily due to (1) cash paid for withholding tax related to net share settlement of restricted share units of $11.4 million, (2) repayment of loans to banks of $9.1 million, and (3) repurchase of ordinary shares of $8.3 million.
Recent Accounting Pronouncements
See Note 2 of Notes to Unaudited Condensed Consolidated Financial Statements for recent accounting pronouncements that could have an effect on us.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Interest Rate Risk
We had cash, cash equivalents, restricted cash and short-term investments totaling $515.1 million and $548.1 million as of March 25, 2022 and June 25, 2021, respectively. We have interest rate risk exposure relating to the interest income generated by excess cash invested in highly liquid investments with maturities of three months or less from the original dates of purchase. The cash, cash equivalents, and short-term investments are held for working capital purposes. We have not used derivative financial instruments in our investment portfolio. We have not been exposed nor do we anticipate being exposed to material risks due to changes in market interest rates. Declines in interest rates, however, will reduce future investment income. If overall interest rates had declined by 10 basis points during the nine months ended March 25, 2022 and March 26, 2021, our interest income would have decreased by approximately $0.2 million and $0.3 million, respectively, assuming consistent investment levels.
We also have interest rate risk exposure in movements in interest rates associated with our interest bearing liabilities. The interest bearing liabilities are denominated in U.S. dollars and the interest expense is based on the London Inter-Bank Offered Rate (LIBOR), plus an additional margin, depending on the lending institution. If the LIBOR had increased by 100 basis points during the nine months ended March 25, 2022 and March 26, 2021, our interest expense would have increased by approximately $0.3 million for both periods, assuming consistent borrowing levels.
We therefore entered into interest rate swap agreements (the “Swap Agreements”) to manage this risk and increase the profile of our debt obligation. The terms of the Swap Agreements allow us to effectively convert the floating interest rate to a fixed interest rate. This locks the variable interest expenses associated with our floating rate borrowings and results in fixed interest expenses that are unsusceptible to market rate increases. We designated the Swap Agreements as a cash flow hedge, and they qualify for hedge accounting because the hedges are highly effective. While we intend to continue to meet the conditions for hedge accounting, if hedges do not qualify as highly effective, the changes in the fair value of the derivatives used as hedges would be reflected in our earnings. From September 27, 2019, any gains or losses related to these outstanding interest rate swaps will be recorded in accumulated other comprehensive income in the consolidated balance sheets, with subsequent reclassification to interest expense when settled.
We maintain an investment portfolio in a variety of financial instruments, including, but not limited to, U.S. government and agency bonds, corporate obligations, money market funds, asset-backed securities, and other investment-grade securities. The majority of these investments pay a fixed rate of interest. The securities in the investment portfolio are subject to market price risk due to changes in interest rates, perceived issuer creditworthiness, marketability, and other factors. These investments
43
are generally classified as available-for-sale and, consequently, are recorded on our unaudited condensed consolidated balance sheets at fair value with unrealized gains or losses reported as a separate component of shareholders’ equity.
Investments in both fixed-rate and floating-rate interest earning instruments carry a degree of interest rate risk. The fair market values of our fixed-rate securities decline if interest rates rise, while floating-rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may be less than we expect because of changes in interest rates or we may suffer losses in principal if forced to sell securities that have experienced a decline in market value because of changes in interest rates.
Foreign Currency Risk
As a result of our foreign operations, we have significant expenses, assets and liabilities that are denominated in foreign currencies. Substantially all of our employees and most of our facilities are located in Thailand, the PRC and the United Kingdom. Therefore, a substantial portion of our payroll as well as certain other operating expenses are paid in Thai baht, RMB and GBP. The significant majority of our revenues are denominated in U.S. dollars because our customer contracts generally provide that our customers will pay us in U.S. dollars.
As a consequence, our gross profit margins, operating results, profitability and cash flows are adversely impacted when the dollar depreciates relative to the Thai baht, the GBP or the RMB. We have a particularly significant currency rate exposure to changes in the exchange rate between the Thai baht, the GBP, the RMB and the U.S. dollar. We must translate foreign currency-denominated results of operations, assets and liabilities for our foreign subsidiaries to U.S. dollars in our unaudited condensed consolidated financial statements. Consequently, increases and decreases in the value of the U.S. dollar compared with such foreign currencies will affect our reported results of operations and the value of our assets and liabilities on our unaudited condensed consolidated balance sheets, even if our results of operations or the value of those assets and liabilities has not changed in its original currency. These transactions could significantly affect the comparability of our results between financial periods or result in significant changes to the carrying value of our assets, liabilities and shareholders’ equity.
We attempt to hedge against these exchange rate risks by entering into derivative instruments that are typically one to eighteen months in duration, leaving us exposed to longer term changes in exchange rates. Beginning December 28, 2019, we designated the foreign currency forward contracts used to hedge fluctuations in the U.S. dollar value of forecasted transactions denominated in Thai baht as cash flow hedges, as they qualified for hedge accounting because the hedges are highly effective. While we intend to continue to meet the conditions for hedge accounting, if hedges do not qualify as highly effective, the changes in the fair value of the derivatives used as hedges would be reflected in our earnings. Any gains or losses related to these outstanding foreign currency forward contracts will be recorded in accumulated other comprehensive income (loss) in the unaudited condensed consolidated balance sheets, with subsequent reclassification to the same statement of operations and comprehensive income line item as the earnings effect of hedge items when settled. We recorded unrealized gain of $0.6 million and unrealized loss of $1.7 million for the nine months ended March 25, 2022 and March 26, 2021, respectively, related to derivatives that are not designated as hedging instruments. As foreign currency exchange rates fluctuate relative to the U.S. dollar, we expect to incur foreign currency translation adjustments and may incur foreign currency exchange losses. For example, a 10% weakening in the U.S. dollar against the Thai baht, the RMB and the GBP would have resulted in a decrease in our net dollar position of approximately $5.5 million and $1.4 million as of March 25, 2022 and June 25, 2021, respectively. We cannot give any assurance as to the effect that future changes in foreign currency rates will have on our unaudited condensed consolidated financial position, operating results or cash flows.
Credit Risk
Credit risk refers to our exposures to financial institutions, suppliers and customers that have in the past and may in the future experience financial difficulty, particularly in light of recent conditions in the credit markets and the global economy. As of March 25, 2022, our cash and cash equivalents were held in deposits and highly liquid investment products with maturities of three months or less with banks and other financial institutions having credit ratings of A minus or above. Our short-term investments as of March 25, 2022 are held in various financial institutions with a maturity limit not to exceed three years, and all securities are rated A1, P-1, F1 or better. We continue to monitor our surplus cash and consider investment in corporate and U.S. government debt as well as certain available for sale securities in accordance with our investment policy. We generally monitor the financial performance of our suppliers and customers, as well as other factors that may affect their access to capital and liquidity. Presently, we believe that we will not incur material losses due to our exposures to such credit risk.
44
ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, our chief executive officer and chief financial officer concluded that as of the end of the period covered by this Quarterly Report on Form10-Q, our disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and include controls and procedures designed to ensure that the information required to be disclosed by us in such reports is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosures. Management’s assessment of the effectiveness of our internal control over financial reporting is expressed at the level of reasonable assurance because a control system, no matter how well designed and operated, can provide only reasonable, but not absolute, assurance that the control system’s objectives will be met.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the three months ended March 25, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
45
PART II: OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
From time to time, we may be involved in litigation relating to claims arising in the ordinary course of our business. There are currently no material claims or actions pending or threatened against us.
ITEM 1A. RISK FACTORS
Investing in our ordinary shares involves a high degree of risk. You should carefully consider the following risks, as well as the other information contained in this Quarterly Report on Form10-Q, including our unaudited condensed consolidated financial statements and the related notes, before investing in our ordinary shares. The risks and uncertainties described below are not the only ones that we may face. Additional risks and uncertainties of which we are unaware, or that we currently deem immaterial, also may become important factors that affect us or our ordinary shares. If any of the following risks actually occur, they may harm our business, financial condition and operating results. In this event, the market price of our ordinary shares could decline and you could lose some or all of your investment.
COVID-19 Updates
The COVID-19 pandemic has adversely affected the global economy, disrupted global supply chains and created significant volatility in the financial markets. In addition, the pandemic has resulted in travel restrictions, business closures and the institution of quarantines and other restrictions on movement in many communities.
The extent of the impact of COVID-19 on our future business, financial condition and operating results will depend largely on future developments, including (i) the duration and magnitude of the pandemic; (ii) the measures taken by governmental authorities and private sectors to limit the spread of COVID-19; (iii) our ability to continue providing products and services; and (iv) the effect of the pandemic on our customers, all of which are highly uncertain and cannot be predicted. While we have updated our risk factors to reflect risks of which we are aware, this situation is changing rapidly and additional impacts may arise that we are not aware of currently.
Company and Operational Risks
Our sales depend on a small number of customers. A reduction in orders from any of these customers, the loss of any of these customers, or a customer exerting significant pricing and margin pressures on us could harm our business, financial condition and operating results.
We have depended, and will continue to depend, upon a small number of customers for a significant percentage of our total revenues. During each of the three months ended March 25, 2022 and March 26, 2021, we had three customers that each contributed 10% or more of our revenues. Such customers together accounted for 53.5% and 47.7% of our revenues during the respective periods. During each of the nine months ended March 25, 2022 and March 26, 2021, we had three customers that each contributed 10% or more of our revenues. Such customers together accounted for 54.3% and 46.3% of our revenues during the respective periods. Dependence on a small number of customers means that a reduction in orders from, a loss of, or other adverse actions by any one of these customers would reduce our revenues and could have a material adverse effect on our business, financial condition and operating results.
Further, our customer concentration increases the concentration of our accounts receivable and our exposure to payment default by any of our key customers. Many of our existing and potential customers have substantial debt burdens, have experienced financial distress or have static or declining revenues, all of which may be exacerbated by the sudden and continuing global economic downturn and uncertainty due to COVID-19 and subsequent adverse conditions in the credit markets, the impact of the U.S.-China trade dispute, and the impact of Brexit. Certain of our customers have gone out of business, declared bankruptcy, been acquired, or announced their withdrawal from segments of the optics market. We generate significant accounts payable and inventory for the services that we provide to our customers, which could expose us to substantial and potentially unrecoverable costs if we do not receive payment from our customers.
Our reliance on a small number of customers gives our customers substantial purchasing power and leverage in negotiating contracts with us. In addition, although we enter into master supply agreements with our customers, the amount of business to be transacted under those agreements is not guaranteed. Instead, we are awarded business under those agreements on a project-by-project basis. Some of our customers have at times significantly reduced or delayed the volume of manufacturing services that they order from us. If we are unable to maintain our relationships with our existing significant customers at existing volumes, our business, financial condition and operating results could be harmed.
46
Consolidation in the markets we serve could harm our business, financial condition and operating results.
Consolidation in the markets we serve has resulted in a reduction in the number of potential customers for our services. For example, II-VI Incorporated (“II-VI”) entered into an agreement in March 2021 to acquire Coherent, Inc., Cisco Systems, Inc. completed its acquisition of Acacia Communications Inc. in March 2021, II-VI completed its acquisition of Finisar Corporation in September 2019, and Lumentum Holdings Inc. completed its acquisition of Oclaro, Inc. in December 2018. In some cases, consolidation among our customers has led to a reduction in demand for our services as customers have acquired the capacity to manufacture products in-house.
Consolidation among our customers and their customers will continue to adversely affect our business, financial condition and operating results in several ways. Consolidation among our customers and their customers may result in a smaller number of large customers whose size and purchasing power give them increased leverage that may result in, among other things, decreases in our average selling prices. In addition to pricing pressures, this consolidation may also reduce overall demand for our manufacturing services if customers obtain new capacity to manufacture products in-house or discontinue duplicate or competing product lines in order to streamline operations. If demand for our manufacturing services decreases, our business, financial condition and operating results could be harmed.
If the optical communications market does not expand as we expect, our business may not grow as fast as we expect, which could adversely impact our business, financial condition and operating results.
Revenues from the optical communications end market represented 78.0% and 75.5% of our revenues for the three months ended March 25, 2022 and March 26, 2021, respectively. Our future success as a provider of precision optical, electro-mechanical and electronic manufacturing services for the optical communications market depends on the continued growth of the optics industry and, in particular, the continued expansion of global information networks, particularly those directly or indirectly dependent upon a fiber optic infrastructure. As part of that growth, we anticipate that demand for voice, video, and other data services delivered over high-speed connections (both wired and wireless) will continue to increase. Without network and bandwidth growth, the need for enhanced communications products would be jeopardized. Currently, demand for network services and for high-speed broadband access, in particular, is increasing but growth may be limited by several factors, including, among others: (1) relative strength or weakness of the global economy or certain countries or regions, (2) an uncertain regulatory environment, and (3) uncertainty regarding long-term sustainable business models as multiple industries, such as the cable, traditional telecommunications, wireless and satellite industries, offer competing content delivery solutions. The optical communications market also has experienced periods of overcapacity, some of which have occurred even during periods of relatively high network usage and bandwidth demands. If the factors described above were to slow, stop or reverse the expansion in the optical communications market, our business, financial condition and operating results would be negatively affected.
Our quarterly revenues, gross profit margins and operating results have fluctuated significantly and may continue to do so in the future, which may cause the market price of our ordinary shares to decline or be volatile.
Our quarterly revenues, gross profit margins and operating results have fluctuated significantly and may continue to fluctuate significantly in the future. For example, any of the risks described in this “Risk Factors” section and, in particular, the following factors, could cause our revenues, gross profit margins and operating results to fluctuate from period to period:
•any reduction in customer demand or our ability to fulfill customer orders as a result of disruptions in our supply chain caused by COVID-19;
•our ability to acquire new customers and retain our existing customers by delivering superior product quality and customer service;
•the cyclicality of the optical communications market, as well as the industrial lasers, medical and sensors markets;
•competition;
•our ability to achieve favorable pricing for our services;
•the effect of fluctuations in foreign currency exchange rates;
•our ability to manage our headcount and other costs; and
•changes in the relative mix in our revenues.
47
Therefore, we believe that quarter-to-quarter comparisons of our operating results may not be useful in predicting our future operating results. You should not rely on our results for one quarter as any indication of our future performance. Quarterly variations in our operations could result in significant volatility in the market price of our ordinary shares.
If we are unable to continue diversifying our precision optical and electro-mechanical manufacturing services across other markets within the optics industry, such as the semiconductor processing, biotechnology, metrology and material processing markets, or if these markets do not grow as fast as we expect, our business may not grow as fast as we expect, which could adversely impact our business, financial condition and operating results.
We intend to continue diversifying across other markets within the optics industry, such as the semiconductor processing, biotechnology, metrology, and material processing markets, to reduce our dependence on the optical communications market and to grow our business. Currently, the optical communications market contributes the significant majority of our revenues. There can be no assurance that our efforts to further expand and diversify into other markets within the optics industry will prove successful or that these markets will continue to grow as fast as we expect. In the event that the opportunities presented by these markets prove to be less than anticipated, if we are less successful than expected in diversifying into these markets, or if our margins in these markets prove to be less than expected, our growth may slow or stall, and we may incur costs that are not offset by revenues in these markets, all of which could harm our business, financial condition and operating results.
We face significant competition in our business. If we are unable to compete successfully against our current and future competitors, our business, financial condition and operating results could be harmed.
Our current and prospective customers tend to evaluate our capabilities against the merits of their internal manufacturing as well as the capabilities of other third-party manufacturers. We believe the internal manufacturing capabilities of current and prospective customers are our primary competition. This competition is particularly strong when our customers have excess manufacturing capacity, as was the case when the markets that we serve experienced a significant downturn in 2008 and 2009 that resulted in underutilized capacity. Should our existing and potential customers have excess manufacturing capacity at their facilities, it could adversely affect our business. In addition, as a result of the 2011 flooding in Thailand, some of our customers began manufacturing products internally or using other third-party manufacturers that were not affected by the flooding. If our customers choose to manufacture products internally rather than to outsource production to us, or choose to outsource to a different third-party manufacturer, our business, financial condition and operating results could be harmed.
Competitors in the market for optical manufacturing services include Benchmark Electronics, Inc., Celestica Inc., Sanmina-SCI Corporation, Jabil Circuit, Inc., and Venture Corporation Limited. Our customized optics and glass operations face competition from companies such as Browave Corporation, Fujian Castech Crystals, Inc., Photop Technologies, Inc., and Research Electro-Optic, Inc. Our U.K. competitors for printed circuit board assemblies include STI Limited and Axiom Manufacturing Services Limited. Other existing contract manufacturing companies, original design manufacturers or outsourced semiconductor assembly and test companies could also enter our target markets. In addition, we may face new competitors as we attempt to penetrate new markets.
Many of our customers and potential competitors have longer operating histories, greater name recognition, larger customer bases and significantly greater resources than we have. These advantages may allow them to devote greater resources than we can to the development and promotion of service offerings that are similar or superior to our service offerings. These competitors may also engage in more extensive research and development, undertake more far-reaching marketing campaigns, adopt more aggressive pricing policies or offer services that achieve greater market acceptance than ours. These competitors may also compete with us by making more attractive offers to our existing and potential employees, suppliers, and strategic partners. Further, consolidation in the optics industry could lead to larger and more geographically diverse competitors. New and increased competition could result in price reductions for our services, reduced gross profit margins or loss of market share. We may not be able to compete successfully against our current and future competitors, and the competitive pressures we face may harm our business, financial condition and operating results.
48
Cancellations, delays or reductions of customer orders and the relatively short-term nature of the commitments of our customers could harm our business, financial condition and operating results.
We do not typically obtain firm purchase orders or commitments from our customers that extend beyond 13 weeks. While we work closely with our customers to develop forecasts for periods of up to one year, these forecasts are not binding and may be unreliable. Customers may cancel their orders, change production quantities from forecasted volumes or delay production for a number of reasons beyond our control. Any material delay, cancellation or reduction of orders could cause our revenues to decline significantly and could cause us to hold excess materials. Many of our costs and operating expenses are fixed. As a result, a reduction in customer demand could decrease our gross profit and harm our business, financial condition and operating results. For example, in the six months ended June 26, 2020, we experienced some order cancellations and delays with respect to telecom products that we manufacture for our customers due to COVID-19; however, these cancellations and delays were partially offset by increased demand for datacom products.
In addition, we make significant decisions, including production schedules, material procurement commitments, personnel needs and other resource requirements, based on our estimate of our customers’ requirements. The short-term nature of our customers’ commitments and the possibility of rapid changes in demand for their products reduce our ability to accurately estimate the future requirements of our customers. Inability to forecast the level of customer orders with certainty makes it difficult to allocate resources to specific customers, order appropriate levels of materials and maximize the use of our manufacturing capacity. This could also lead to an inability to meet a spike in production demand, all of which could harm our business, financial condition and operating results.
Our exposure to financially troubled customers or suppliers could harm our business, financial condition and operating results.
Some of our customers and suppliers have in the past and may in the future experience financial difficulty, particularly in light of the sudden and continuing global economic downturn and uncertainty due to the COVID-19 pandemic and subsequent adverse conditions in the credit markets that have affected access to capital and liquidity. As a result, we devote significant resources to monitor receivables and inventory balances with certain of our customers. If our customers experience financial difficulty, we could have difficulty recovering amounts owed to us from these customers, or demand for our services from these customers could decline. If our suppliers experience financial difficulty, we could have trouble sourcing materials necessary to fulfill production requirements and meet scheduled shipments. Any such financial difficulty could adversely affect our operating results and financial condition by resulting in a reduction in our revenues, a charge for inventory write-offs, a provision for doubtful accounts, and larger working capital requirements due to increased days in inventory and days in accounts receivable.
We purchase some of the critical materials used in certain of our products from a single source or a limited number of suppliers. Supply shortages have in the past, and could in the future, impair the quality, reduce the availability or increase the cost of materials, which could harm our revenues, profitability and customer relations.
We rely on a single source or a limited number of suppliers for critical materials used in a significant number of the products we manufacture. We generally purchase these single or limited source materials through standard purchase orders and do not maintain long-term supply agreements with our suppliers. We generally use a rolling 12-month forecast based on anticipated product orders, customer forecasts, product order history, backlog, and warranty and service demand to determine our materials requirements. Lead times for the parts and components that we order vary significantly and depend on factors such as manufacturing cycle times, manufacturing yields, and the availability of raw materials used to produce the parts or components. Historically, we have experienced supply shortages resulting from various causes, including reduced yields by our suppliers, which prevented us from manufacturing products for our customers in a timely manner. More recently, for the six months ended June 26, 2020, we experienced significant fluctuations in the availability of certain materials due to COVID-19, which had an adverse impact on our revenue and costs. Currently, we are experiencing various levels of semiconductor impact due to a significant global shortage. The semiconductor supply chain is complex, and a constrained wafer capacity is occurring deep in the chain. During the COVID-19 pandemic, there has been a surging demand for consumer electronics, which in turn has increased the demand for semiconductors. At the same time, wafer foundries that support chipmakers have not invested enough in recent years to increase capacities to the levels needed to support current demand from all of their customers. Wafers have a long lead time for production, in some cases up to 30 weeks, which further exacerbates the shortage. A shortage of semiconductors or other key components can cause a significant disruption to our production schedule and have a substantial adverse effect on our business, financial condition and operating results.
Our revenues, profitability and customer relations will be harmed by continued fluctuations in the availability of materials, a stoppage or delay of supply, a substitution of more expensive or less reliable parts, the receipt of defective parts or
49
contaminated materials, an increase in the price of supplies, or an inability to obtain reductions in price from our suppliers in response to competitive pressures. We continue to undertake programs to strengthen our supply chain. Nevertheless, we are experiencing, and expect for the foreseeable future to experience, strain on our supply chain, as well as periodic supplier problems. These supply chain issues have impacted, and will continue to impact, our ability to generate revenue. In addition, we have incurred, and expect for the foreseeable future to incur, increased costs related to our efforts to address these problems.
Managing our inventory is complex and may require write-downs due to excess or obsolete inventory, which could cause our operating results to decrease significantly in a given fiscal period.
Managing our inventory is complex. We are generally required to procure materials based upon the anticipated demand of our customers. The inaccuracy of these forecasts or estimates could result in excess supply or shortages of certain materials. Inventory that is not used or expected to be used as and when planned may become excess or obsolete. Generally, we are unable to use most of the materials purchased for one of our customers to manufacture products for any of our other customers. Additionally, we could experience reduced or delayed product shipments or incur additional inventory write-downs and cancellation charges or penalties, which would increase costs and could harm our business, financial condition and operating results. While our agreements with customers are structured to mitigate our risks related to excess or obsolete inventory, enforcement of these provisions may result in material expense, and delay in payment for inventory. If any of our significant customers becomes unable or unwilling to purchase inventory or does not agree to such contractual provisions in the future, our business, financial condition and operating results may be harmed.
If we fail to adequately expand our manufacturing capacity, we will not be able to grow our business, which would harm our business, financial condition and operating results. Conversely, if we expand too much or too rapidly, we may experience excess capacity, which would harm our business, financial condition and operating results.
We may not be able to pursue many large customer orders or sustain our historical growth rates if we do not have sufficient manufacturing capacity to enable us to commit to provide customers with specified quantities of products. If our customers do not believe that we have sufficient manufacturing capacity, they may: (1) outsource all of their production to another manufacturer that they believe can fulfill all of their production requirements; (2) look to a second manufacturer for the manufacture of additional quantities of the products that we currently manufacture for them; (3) manufacture the products themselves; or (4) decide against using our services for their new products.
Most recently, we expanded our manufacturing capacity by building a new facility in Chonburi, Thailand in March 2017, and we began construction of a new building at our Chonburi campus in January 2021. We may continue to devote significant resources to the expansion of our manufacturing capacity, and any such expansion will be expensive, will require management’s time and may disrupt our operations. In the event we are unsuccessful in our attempts to expand our manufacturing capacity, our business, financial condition and operating results could be harmed.
However, if we successfully expand our manufacturing capacity but are unable to promptly utilize the additional space due to reduced demand for our services or an inability to win new projects, add new customers or penetrate new markets, or if the optics industry does not grow as we expect, we may experience periods of excess capacity, which could harm our business, financial condition and operating results.
We may experience manufacturing yields that are lower than expected, potentially resulting in increased costs, which could harm our business, operating results and customer relations.
Manufacturing yields depend on a number of factors, including the following:
•the quality of input, materials and equipment;
•the quality and feasibility of our customer’s design;
•the repeatability and complexity of the manufacturing process;
•the experience and quality of training of our manufacturing and engineering teams; and
•the monitoring of the manufacturing environment.
Lower volume production due to continually changing designs generally results in lower yields. Manufacturing yields and margins can also be lower if we receive or inadvertently use defective or contaminated materials from our suppliers. In addition, our customer contracts typically provide that we will supply products at a fixed price each quarter, which assumes specific production yields and quality metrics. If we do not meet the yield assumptions and quality metrics used in calculating
50
the price of a product, we may not be able to recover the costs associated with our failure to do so. Consequently, our operating results and profitability may be harmed.
If the products that we manufacture contain defects, we could incur significant correction costs, demand for our services may decline and we may be exposed to product liability and product warranty claims, which could harm our business, financial condition, operating results and customer relations.
We manufacture products to our customers’ specifications, and our manufacturing processes and facilities must comply with applicable statutory and regulatory requirements. In addition, our customers’ products and the manufacturing processes that we use to produce them are often complex. As a result, products that we manufacture may at times contain manufacturing or design defects, and our manufacturing processes may be subject to errors or fail to be in compliance with applicable statutory or regulatory requirements. Additionally, not all defects are immediately detectable. The testing procedures of our customers are generally limited to the evaluation of the products that we manufacture under likely and foreseeable failure scenarios. For various reasons (including, among others, the occurrence of performance problems that are unforeseeable at the time of testing or that are detected only when products are fully deployed and operated under peak stress conditions), these products may fail to perform as expected after their initial acceptance by a customer.
We generally provide a warranty of between one to five years on the products that we manufacture for our customers. This warranty typically guarantees that products will conform to our customers’ specifications and be free from defects in workmanship. Defects in the products we manufacture, whether caused by a design, engineering, manufacturing or component failure or by deficiencies in our manufacturing processes, and whether such defects are discovered during or after the warranty period, could result in product or component failures, which may damage our business reputation, whether or not we are indemnified for such failures. We could also incur significant costs to repair or replace defective products under warranty, particularly when such failures occur in installed systems. In some instances, we may also be required to incur costs to repair or replace defective products outside of the warranty period in the event that a recurring defect is discovered in a certain percentage of a customer’s products delivered over an agreed upon period of time. We have experienced product or component failures in the past and remain exposed to such failures, as the products that we manufacture are widely deployed throughout the world in multiple environments and applications. Further, due to the difficulty in determining whether a given defect resulted from our customer’s design of the product or our manufacturing process, we may be exposed to product liability or product warranty claims arising from defects that are not attributable to our manufacturing process. In addition, if the number or type of defects exceeds certain percentage limitations contained in our contractual arrangements, we may be required to conduct extensive failure analysis, re-qualify for production or cease production of the specified products.
Product liability claims may include liability for personal injury or property damage. Product warranty claims may include liability for a recall, repair or replacement of a product or component. Although liability for these claims is generally assigned to our customers in our contracts, even where they have assumed liability our customers may not, or may not have the resources to, satisfy claims for costs or liabilities arising from a defective product. Additionally, under one of our contracts, in the event the products we manufacture do not meet the end-customer’s testing requirements or otherwise fail, we may be required to pay penalties to our customer, including a fee during the time period that the customer or end-customer’s production line is not operational as a result of the failure of the products that we manufacture, all of which could harm our business, operating results and customer relations. If we engineer or manufacture a product that is found to cause any personal injury or property damage or is otherwise found to be defective, we could incur significant costs to resolve the claim. While we maintain insurance for certain product liability claims, we do not maintain insurance for any recalls and, therefore, would be required to pay any associated costs that are determined to be our responsibility. A successful product liability or product warranty claim in excess of our insurance coverage or any material claim for which insurance coverage is denied, limited, is not available or has not been obtained could harm our business, financial condition and operating results.
If we fail to attract additional skilled employees or retain key personnel, our business, financial condition and operating results could suffer.
Our future success depends, in part, upon our ability to attract additional skilled employees and retain our current key personnel. We have identified several areas where we intend to expand our hiring, including business development, finance, human resources, operations and supply chain management. We may not be able to hire and retain such personnel at compensation levels consistent with our existing compensation and salary structure. Our future also depends on the continued contributions of our executive management team and other key management and technical personnel, each of whom would be difficult to replace. Although we have key person life insurance policies on some of our executive officers, the loss of any of our executive officers or key personnel or the inability to continue to attract qualified personnel could harm our business, financial condition and operating results.
51
Risks Related to Our International Operations
We conduct operations in a number of countries, which creates logistical and communications challenges for us and exposes us to other risks and challenges that could harm our business, financial condition and operating results.
The vast majority of our operations, including manufacturing and customer support, are located primarily in the Asia-Pacific region. The distances between Thailand, the PRC and our customers and suppliers globally, create a number of logistical and communications challenges for us, including managing operations across multiple time zones, directing the manufacture and delivery of products across significant distances, coordinating the procurement of raw materials and their delivery to multiple locations and coordinating the activities and decisions of our management team, the members of which are based in different countries.
Our customers are located throughout the world, and our principal manufacturing facilities are located in Thailand. Revenues from the bill-to-location of customers outside of North America accounted for 47.5% and 51.8% of our revenues for the three months ended March 25, 2022 and March 26, 2021, respectively. We expect that revenues from the bill-to-location of customers outside of North America will continue to account for a significant portion of our revenues. Our customers also depend on international sales, which further exposes us to the risks associated with international operations. Conducting business outside the United States subjects us to a number of additional risks and challenges, including:
•compliance with a variety of domestic and foreign laws and regulations, including trade regulatory requirements;
•periodic changes in a specific country or region’s economic conditions, such as recession;
•unanticipated restrictions on our ability to sell to foreign customers where sales of products and the provision of services may require export licenses or are prohibited by government action (for example, in early 2018, the U.S. Department of Commerce prohibited the export and sale of a broad category of U.S. products, as well as the provision of services, to ZTE Corporation, and in 2019, to Huawei, both of which are customers of certain of our customers);
•fluctuations in currency exchange rates;
•inadequate protection of intellectual property rights in some countries; and
•potential political, legal and economic instability, foreign conflicts, and the impact of regional and global infectious illnesses in the countries in which we and our customers and suppliers are located (for example, disruptions to international operations associated with the occurrence of the COVID-19 pandemic or the ongoing armed conflict in Ukraine).
Our failure to manage the risks and challenges associated with our international operations could have a material adverse effect on our business.
We are subject to governmental export and import controls in several jurisdictions that subject us to a variety of risks, including liability, impairment of our ability to compete in international markets, and decreased sales and customer orders.
We are subject to governmental export and import controls in Thailand, the PRC, the United Kingdom and the United States that may limit our business opportunities. Various countries regulate the import of certain technologies and have enacted laws or taken actions that could limit (1) our ability to export or sell the products we manufacture and (2) our customers’ ability to export or sell products that we manufacture for them. The export of certain technologies from the United States, the United Kingdom and other nations to the PRC is barred by applicable export controls, and similar prohibitions could be extended to Thailand, thereby limiting our ability to manufacture certain products. Any change in export or import regulations or related legislation, shift in approach to the enforcement of existing regulations, or change in the countries, persons or technologies targeted by such regulations, could limit our ability to offer our manufacturing services to existing or potential customers, which could harm our business, financial condition and operating results.
For example, in May 2019, the U.S. Commerce Department’s Bureau of Industry and Security ("BIS") added Huawei and certain affiliates to the BIS Entity List. This action denied Huawei the ability to purchase products, software and technology that are subject to U.S. Export Administration Regulations. Although we do not sell directly to Huawei, some of our customers do sell to Huawei directly. To ensure compliance, some of our customers immediately suspended shipments to Huawei in order to begin assessments of the products they sold to Huawei (and its affiliates), to determine whether these products were subject to the restrictions resulting from the ban. This had an immediate impact on our customer orders in the fourth quarter of fiscal year 2019, which affected our revenue for that quarter. We expect this ban to continue to adversely affect orders from our customers for the foreseeable future.
52
We are subject to risks related to the ongoing U.S.-China trade dispute, including increased tariffs on materials that we use in manufacturing, which could adversely affect our business, financial condition and operating results.
In August 2019, the U.S. imposed tariffs on a wide range of products and goods manufactured in the PRC that are directly or indirectly imported into the U.S. Although the U.S. announced on January 15, 2020 the reduction of certain tariffs on Chinese imported goods and delayed the implementation of certain other related tariffs, we have no assurance that the U.S. will not continue to increase or impose tariffs on imports from the PRC or alter trade agreements and terms between the PRC and the U.S., which may include limiting trade with the PRC. Trade restrictions, including tariffs, quotas, embargoes, safeguards and customs restrictions, could increase the cost of materials we use to manufacture certain products, which could result in lower margins. The tariffs could also result in disruptions to our supply chain, as suppliers struggle to fill orders from companies trying to purchase goods in bulk ahead of announced tariffs taking effect. The institution of trade tariffs both globally and between the U.S. and the PRC specifically could also cause a decrease in the sales of our customers’ products to end-users located in the PRC, which could directly impact our revenues in the form of reduced orders. If existing tariffs are raised further, or if new tariffs are imposed on additional categories of components used in our manufacturing activities, and if we are unable to pass the costs of such tariffs on to our customers, our operating results would be harmed.
Fluctuations in foreign currency exchange rates and changes in governmental policies regarding foreign currencies could increase our operating costs, which would adversely affect our operating results.
Volatility in the functional and non-functional currencies of our entities and the U.S. dollar could seriously harm our business, financial condition and operating results. The primary impact of currency exchange fluctuations is on our cash, receivables, and payables of our operating entities. We may experience significant unexpected losses from fluctuations in exchange rates. For example, in the three months ended March 29, 2019, we experienced a $3.1 million foreign exchange loss, which negatively affected our net income per share for the same period by $0.08.
Our customer contracts generally require that our customers pay us in U.S. dollars. However, the majority of our payroll and other operating expenses are paid in Thai baht. As a result of these arrangements, we have significant exposure to changes in the exchange rate between the Thai baht and the U.S. dollar, and our operating results are adversely impacted when the U.S. dollar depreciates relative to the Thai baht and other currencies. We have experienced such depreciation in the U.S. dollar as compared with the Thai baht, and our results have been adversely impacted by this fluctuation in exchange rates. As of March 25, 2022, the U.S. dollar had appreciated approximately 3.2% against the Thai baht since March 27, 2020. Further, while we attempt to hedge against certain exchange rate risks, we typically enter into hedging contracts with maturities of up to 12 months, leaving us exposed to longer term changes in exchange rates.
Additionally, we have significant exposure to changes in the exchange rate between the Chinese Renminbi (“RMB”) and pound sterling (“GBP”) and the U.S. dollar. The expenses of our subsidiaries located in the PRC and the United Kingdom are denominated in RMB and GBP, respectively. Currently, RMB are convertible in connection with trade- and service-related foreign exchange transactions, foreign debt service, and payment of dividends. The PRC government may at its discretion restrict access in the future to foreign currencies for current account transactions. If this occurs, our PRC subsidiary may not be able to pay us dividends in U.S. dollars without prior approval from the PRC State Administration of Foreign Exchange. In addition, conversion of RMB for most capital account items, including direct investments, is still subject to government approval in the PRC. This restriction may limit our ability to invest the earnings of our PRC subsidiary. As of March 25, 2022, the U.S. dollar had depreciated approximately 10.1% against the RMB since March 27, 2020. There remains significant international pressure on the PRC government to adopt a substantially more liberalized currency policy. GBP are convertible in connection with trade- and service-related foreign exchange transactions and foreign debt service. As of March 25, 2022, the U.S. dollar had depreciated approximately 7.5% against the GBP since March 27, 2020. Any appreciation in the value of the RMB and GBP against the U.S. dollar could negatively impact our operating results.
Political unrest and demonstrations, as well as changes in the political, social, business or economic conditions in Thailand, could harm our business, financial condition and operating results.
The majority of our assets and manufacturing operations are located in Thailand. Therefore, political, social, business and economic conditions in Thailand have a significant effect on our business. In March 2022, Thailand was assessed as a medium political risk by Marsh, an insurance broker and risk advisor. Any changes to tax regimes, laws, exchange controls or political action in Thailand may harm our business, financial condition and operating results.
Thailand has a history of political unrest that includes the involvement of the military as an active participant in the ruling government. In recent years, political unrest in the country has sparked political demonstrations and, in some instances, violence. Any future political instability in Thailand could prevent shipments from entering or leaving the country, disrupt our
53
ability to manufacture products in Thailand, and force us to transfer our operations to more stable, and potentially more costly, regions, which would harm our business, financial condition and operating results.
Further, the Thai government may raise the minimum wage standards for labor and could repeal certain promotional certificates that we have received or tax holidays for certain export and value added taxes that we enjoy, either preventing us from engaging in our current or anticipated activities or subjecting us to higher tax rates.
We expect to continue to invest in our manufacturing operations in the PRC, which will continue to expose us to risks inherent in doing business in the PRC, any of which risks could harm our business, financial condition and operating results.
We anticipate that we will continue to invest in our customized optics manufacturing facilities located in Fuzhou, the PRC. Because these operations are located in the PRC, they are subject to greater political, legal and economic risks than the geographies in which the facilities of many of our competitors and customers are located. In particular, the political and economic climate in the PRC (both at national and regional levels) is fluid and unpredictable. In March 2022, the PRC was assessed as a medium political risk by Marsh. A large part of the PRC’s economy is still being operated under varying degrees of control by the PRC government. By imposing industrial policies and other economic measures, such as control of foreign exchange, taxation, import and export tariffs, environmental regulations, land use rights, intellectual property and restrictions on foreign participation in the domestic market of various industries, the PRC government exerts considerable direct and indirect influence on the development of the PRC economy. Many of the economic reforms carried out by the PRC government are unprecedented or experimental and are expected to change further. Any changes to the political, legal or economic climate in the PRC could harm our business, financial condition and operating results.
Our PRC subsidiary is a “wholly foreign-owned enterprise” and is therefore subject to laws and regulations applicable to foreign investment in the PRC, in general, and laws and regulations applicable to wholly foreign-owned enterprises, in particular. The PRC has made significant progress in the promulgation of laws and regulations pertaining to economic matters such as corporate organization and governance, foreign investment, commerce, taxation and trade. However, the promulgation of new laws, changes in existing laws and abrogation of local regulations by national laws may have a negative impact on our business and prospects. In addition, these laws and regulations are relatively new, and published cases are limited in volume and non-binding. Therefore, the interpretation and enforcement of these laws and regulations involve significant uncertainties. Laws may be changed with little or no prior notice, for political or other reasons. These uncertainties could limit the legal protections available to foreign investors. Furthermore, any litigation in the PRC may be protracted and result in substantial costs and diversion of resources and management’s attention.
Natural disasters, epidemics (including COVID-19), acts of terrorism and other political and economic developments could harm our business, financial condition and operating results.
Natural disasters could severely disrupt our manufacturing operations and increase our supply chain costs. These events, over which we have little or no control, could cause a decrease in demand for our services, make it difficult or impossible for us to manufacture and deliver products or for our suppliers to deliver components allowing us to manufacture those products, require large expenditures to repair or replace our facilities, or create delays and inefficiencies in our supply chain. For example, the 2011 flooding in Thailand forced us to temporarily shut down all of our manufacturing facilities in Thailand and cease production permanently at our Chokchai facility, which adversely affected our ability to meet our customers’ demands during fiscal year 2012.
In some countries in which we operate, including the PRC, the U.S., the U.K. and Thailand, outbreaks of infectious diseases such as COVID-19, H1N1 influenza virus, severe acute respiratory syndrome (“SARS”) or bird flu could disrupt our manufacturing operations, reduce demand for our customers’ products and increase our supply chain costs. For example, our facility in Fuzhou, the PRC, which manufactures custom optics components, was not permitted to resume operations for a period of two weeks in February 2020 due to the outbreak of COVID-19, which negatively affected our revenues for the three months ended March 27, 2020. In addition, we and some of our suppliers and customers in the PRC experienced labor shortages during the three months ended March 27, 2020, due to travel restrictions imposed by the Chinese government. During the three months ended March 25, 2022, several countries where we have manufacturing facilities, including Thailand, the PRC, the U.S. and the U.K., experienced a surge in the number of COVID-19 cases. We continue to take precautionary measures including implementing leaves of absence for affected employees and their close contacts, stringent contact tracing, enhanced safe distancing measures, and arrangements for the vaccination of our employees in Thailand. Although we did not experience any significant disruptions in our operations or decrease in customer demand during the three months ended March 25, 2022, any worsening of the pandemic may result in more stringent measures being implemented by local authorities, such as shutting down our manufacturing facilities, which would have a significant negative impact on our operations.
54
While we are unable to accurately predict the full impact that COVID-19 will have on our business, financial condition and operating results due to numerous uncertainties, including the duration and severity of the pandemic as well as related containment measures ordered by government authorities, our compliance with such measures has already impacted our day-to-day operations and could continue to disrupt our business, as well as that of our customers, suppliers and other counterparties, for an indefinite period of time.
In addition, increased international political instability, evidenced by the threat or occurrence of terrorist attacks, enhanced national security measures, Russia’s invasion of Ukraine, conflicts in the Middle East and Asia, strained international relations arising from these conflicts and the related decline in consumer confidence and economic weakness, may hinder our ability to do business. Any escalation in these events or similar future events may disrupt our operations and the operations of our customers and suppliers and may affect the availability of materials needed for our manufacturing services. Such events may also disrupt the transportation of materials to our manufacturing facilities and finished products to our customers. These events have had, and may continue to have, an adverse impact on the U.S. and world economy in general, and customer confidence and spending in particular, which in turn could adversely affect our total revenues and operating results. The impact of these events on the volatility of the U.S. and world financial markets also could increase the volatility of the market price of our ordinary shares and may limit the capital resources available to us, our customers and our suppliers.
Financial Risks
The loan agreements for our long-term debt obligations and other credit facilities contain financial ratio covenants that may impair our ability to conduct our business.
The loan agreements for our long-term and short-term debt obligations contain financial ratio covenants that may limit management’s discretion with respect to certain business matters. These covenants require us to maintain a specified maximum total leverage ratio, minimum debt service coverage ratio (earnings before interest and depreciation and amortization plus cash on hand minus short-term debt), a minimum tangible net worth and a minimum quick ratio, which may restrict our ability to incur additional indebtedness and limit our ability to use our cash. In the event of our default on these loans or a breach of a covenant, the lenders may immediately cancel the loan agreement, deem the full amount of the outstanding indebtedness immediately due and payable, charge us interest on a monthly basis on the full amount of the outstanding indebtedness and, if we cannot repay all of our outstanding obligations, sell the assets pledged as collateral for the loan in order to fulfill our obligation. We may also be held responsible for any damages and related expenses incurred by the lender as a result of any default. Any failure by us or our subsidiaries to comply with these agreements could harm our business, financial condition and operating results.
The phase-out of the London Interbank Offered Rate (“LIBOR”) could affect interest rates under our existing credit facility agreement, as well as our ability to seek future debt financing.
LIBOR is the basic rate of interest used in lending between banks on the London interbank market and is widely used as a reference for setting the interest rates on loans globally. We generally use LIBOR as a reference rate to calculate interest rates under our credit facility agreement. In 2017, the U.K.’s Financial Conduct Authority ("FCA"), which regulates LIBOR, announced that it intends to phase out LIBOR by the end of 2021. On March 5, 2021, the FCA announced the dates on which the panel bank submissions for all LIBOR settings will cease, after which representative LIBOR rates will no longer be available. The FCA confirmed that all LIBOR settings will cease to be provided by any administrator or no longer be representative as follows: immediately after December 31, 2021, in the case of all GBP, EUR, CHF and JPY settings, and the 1-week and 2-month USD settings; and immediately after June 30, 2023, in the case of the remaining USD settings.
The U.S. Federal Reserve, in conjunction with the Alternative Reference Rates Committee, a steering committee comprised of large U.S. financial institutions, has identified replacing U.S. dollar LIBOR with a new index, the Secured Overnight Financing Rate, calculated using short-term repurchase agreements backed by Treasury securities. The International Swaps and Derivatives Association ("ISDA") issued a statement on March 5, 2021, in response to the announcement by the FCA on the future cessation and loss of representativeness of LIBOR benchmarks. ISDA confirmed that the FCA’s announcement constitutes an index cessation event under IBOR Fallbacks and Supplements and the ISDA 2020 Fallbacks Protocol for all 35 LIBOR settings. As a result, the fallback spread adjustments were fixed as of the date of the announcement.
The fallbacks will automatically occur for outstanding derivatives contracts that incorporate the IBOR Fallbacks Supplement or are subject to the ISDA 2020 Fallbacks Protocol on the dates immediately after: December 31, 2021, for outstanding derivatives referenced to all EUR, GBP, CHF and JPY LIBOR settings; and June 30, 2023, for outstanding derivatives referenced to all USD LIBOR settings.
55
We have adhered to the ISDA 2020 IBOR Fallbacks Protocol since January 2021 for outstanding interest rate swap agreements which have interest rates referenced to 1-month USD LIBOR and 3-month USD LIBOR; therefore, the fallbacks will automatically occur on June 30, 2023 as described above.
The new rates may not be as favorable to us as those in effect prior to any LIBOR phase-out. In addition, the transition process may involve, among other things, increased volatility or illiquidity in markets for instruments that currently rely on LIBOR. The transition may also result in reductions in the value of certain instruments or the effectiveness of related transactions such as hedges, increased borrowing costs, uncertainty under applicable documentation, or difficult and costly consent processes. Any such effects of the transition away from LIBOR, as well as other unforeseen effects, may result in expenses, difficulties, complications or delays in connection with future financing efforts, which could have a material adverse impact on our business, financial condition and operating results.
Unfavorable worldwide economic conditions may negatively affect our business, operating results and financial condition.
The sudden and continuing global economic downturn and uncertainty due to the effects of COVID-19 and subsequent volatility and adverse conditions in the capital and credit markets have negatively affected levels of business and consumer spending. Concerns about the increasing possibility of a global depression and potential default of various national bonds and debt backed by individual countries, as well as the politics impacting these, could negatively impact the U.S. and global economies and adversely affect our financial results. In particular, the economic disruption caused by COVID-19 has led to reduced demand in some of our customers’ optical communications product portfolios and significant volatility in global stock markets and currency exchange rates. Uncertainty about worldwide economic conditions poses a risk as businesses may further reduce or postpone spending in response to reduced budgets, tight credit, negative financial news and declines in income or asset values, which could adversely affect our business, financial condition and operating results and increase the volatility of our share price. In addition, our ability to access capital markets may be restricted, which could have an impact on our ability to react to changing economic and business conditions and could also adversely affect our business, financial condition and operating results.
Due to the unprecedented and rapidly changing social and global economic impacts associated with COVID-19, we are unable to predict or estimate the ultimate impact on our business or business prospects. The ultimate impact of COVID-19 on our business will depend on, among other factors: the severity and duration of the pandemic; the effects on the global economy; the severity and duration of restrictive measures taken by governmental authorities and other third parties; and the availability of governmental programs implemented to assist businesses impacted by the pandemic. At this time, we cannot estimate the short- or long-term impacts of COVID-19 on our business, financial condition and operating results.
We may not be able to obtain capital when desired on favorable terms, if at all, or without dilution to our shareholders.
We anticipate that our current cash and cash equivalents, together with cash provided by operating activities and funds available through our working capital and credit facilities, will be sufficient to meet our current and anticipated needs for general corporate purposes for at least the next 12 months. However, we operate in a market that makes our prospects difficult to evaluate. It is possible that we may not generate sufficient cash flow from operations or otherwise have the capital resources to meet our future capital needs. If this occurs, we may need additional financing to execute on our current or future business strategies.
Furthermore, if we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our shareholders could be significantly diluted, and these newly-issued securities may have rights, preferences or privileges senior to those of existing shareholders. If adequate additional funds are not available or are not available on acceptable terms, if and when needed, our ability to fund our operations, take advantage of unanticipated opportunities, develop or enhance our manufacturing services, hire additional technical and other personnel, or otherwise respond to competitive pressures could be significantly limited.
Our investment portfolio may become impaired by deterioration of the capital markets.
We use professional investment management firms to manage our excess cash and cash equivalents. Our short-term investments as of March 25, 2022 are primarily investments in a fixed income portfolio, including liquidity funds, certificates of deposit and time deposits, corporate debt securities, and U.S. agency and U.S. Treasury securities. Our investment portfolio
56
may become impaired by deterioration of the capital markets. We follow an established investment policy and set of guidelines to monitor and help mitigate our exposure to interest rate and credit risk. The policy sets forth credit quality standards and limits our exposure to any one issuer, as well as our maximum exposure to various asset classes. The policy also provides that we may not invest in short-term investments with a maturity in excess of three years.
Should financial market conditions worsen, investments in some financial instruments may pose risks arising from market liquidity and credit concerns. In addition, any deterioration of the capital markets could cause our other income and expense to vary from expectations. As of March 25, 2022, we did not record any impairment charges associated with our portfolio of short-term investments, and although we believe our current investment portfolio has little risk of material impairment, we cannot predict future market conditions or market liquidity, or credit availability, and can provide no assurance that our investment portfolio will remain materially unimpaired.
We are not fully insured against all potential losses. Natural disasters or other catastrophes could adversely affect our business, financial condition and operating results.
Our current property and casualty insurance covers loss or damage to our property and third-party property over which we have custody and control, as well as losses associated with business interruption, subject to specified exclusions and limitations such as coinsurance, facilities location sub-limits and other policy limitations and covenants. Even with insurance coverage, natural disasters or other catastrophic events, including acts of war, could cause us to suffer substantial losses in our operational capacity and could also lead to a loss of opportunity and to a potential adverse impact on our relationships with our existing customers resulting from our inability to produce products for them, for which we might not be compensated by existing insurance. This in turn could have a material adverse effect on our business, financial condition and operating results.
There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with U.S. GAAP. Any changes in estimates, judgments and assumptions could have a material adverse effect on our business, financial condition and operating results.
The preparation of financial statements in accordance with U.S. GAAP involves making estimates, judgments and assumptions that affect reported amounts of assets (including intangible assets), liabilities and related reserves, revenues, expenses and income. Estimates, judgments and assumptions are inherently subject to change in the future, and any such changes could result in corresponding changes to the amounts of assets, liabilities, revenues, expenses and income. Any such changes could have a material adverse effect on our business, financial condition and operating results.
Intellectual Property and Cybersecurity Risks
Our business and operations would be adversely impacted in the event of a failure of our information technology infrastructure and/or cyber security attacks.
We rely upon the capacity, availability and security of our information technology hardware and software infrastructure. For instance, we use a combination of standard and customized software platforms to manage, record, and report all aspects of our operations and, in many instances, enable our customers to remotely access certain areas of our databases to monitor yields, inventory positions, work-in-progress status and vendor quality data. We are constantly expanding and updating our information technology infrastructure in response to our changing needs. Any failure to manage, expand and update our information technology infrastructure or any failure in the operation of this infrastructure could harm our business.
Despite our implementation of security measures, our systems are vulnerable to damage caused by computer viruses, natural disasters, unauthorized access and other similar disruptions. Any system failure, accident or security breach could result in disruptions to our operations. To the extent that any disruption, cyber-attack or other security breach results in a loss or damage to our data or inappropriate disclosure of confidential information, our business could be harmed. In addition, we may be required to incur significant costs to protect against damage caused by these disruptions or security breaches in the future.
Intellectual property infringement claims against our customers or us could harm our business, financial condition and operating results.
Our services involve the creation and use of intellectual property rights, which subject us to the risk of intellectual property infringement claims from third parties and claims arising from the allocation of intellectual property rights among us and our customers.
57
Our customers may require that we indemnify them against the risk of intellectual property infringement arising out of our manufacturing processes. If any claims are brought against us or our customers for such infringement, whether or not these claims have merit, we could be required to expend significant resources in defense of such claims. In the event of an infringement claim, we may be required to spend a significant amount of time and money to develop non-infringing alternatives or obtain licenses. We may not be successful in developing such alternatives or obtaining such licenses on reasonable terms or at all, which could harm our business, financial condition and operating results.
Any failure to protect our customers’ intellectual property that we use in the products we manufacture for them could harm our customer relationships and subject us to liability.
We focus on manufacturing complex optical products for our customers. These products often contain our customers’ intellectual property, including trade secrets and know-how. Our success depends, in part, on our ability to protect our customers’ intellectual property. We may maintain separate and secure areas for customer proprietary manufacturing processes and materials and dedicate floor space, equipment, engineers and supply chain management to protect our customers’ proprietary drawings, materials and products. The steps we take to protect our customers’ intellectual property may not adequately prevent its disclosure or misappropriation. If we fail to protect our customers’ intellectual property, our customer relationships could be harmed and we may experience difficulty in establishing new customer relationships. In addition, our customers might pursue legal claims against us for any failure to protect their intellectual property, possibly resulting in harm to our reputation and our business, financial condition and operating results.
Tax, Compliance and Regulatory Risks
We are subject to the risk of increased income taxes, which could harm our business, financial condition and operating results.
We are subject to income and other taxes in Thailand, the PRC, the U.K., the U.S. and Israel. Our effective income tax rate, provision for income taxes and future tax liability could be adversely affected by numerous factors, including the results of tax audits and examinations, income before taxes being lower than anticipated in countries with lower statutory tax rates and higher than anticipated in countries with higher statutory tax rates, changes in income tax rates, changes in the valuation of deferred tax assets and liabilities, failure to meet obligations with respect to tax exemptions, and changes in tax laws and regulations. From time to time, we engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. As of March 25, 2022, our U.S. federal and state tax returns remain open to examination for the tax years 2018 through 2019. In addition, tax returns that remain open to examination in Thailand, the PRC, the U.K. and Israel range from the tax years 2015 through 2021. The results of audits and examinations of previously filed tax returns and continuing assessments of our tax exposures may have an adverse effect on our provision for income taxes and tax liability. For example, in connection with the conclusion of the audit of our U.S. federal and state tax returns for the tax years 2016 and 2017, we incurred additional taxes, interest and penalties.
We base our tax position upon the anticipated nature and conduct of our business and upon our understanding of the tax laws of the various countries in which we have assets or conduct activities. However, our tax position is subject to review and possible challenge by tax authorities and to possible changes in law, which may have retroactive effect. Fabrinet (the “Cayman Islands Parent”) is an exempted company incorporated in the Cayman Islands. We maintain manufacturing operations in Thailand, the PRC, the U.K., the U.S. and Israel. We cannot determine in advance the extent to which some jurisdictions may require us to pay taxes or make payments in lieu of taxes. Under the current laws of the Cayman Islands, we are not subject to tax in the Cayman Islands on income or capital gains until March 6, 2039.
Preferential tax treatment from the Thai government in the form of a corporate tax exemption on income generated from projects to manufacture certain products at our Chonburi campus is available to us through June 2026. Similar preferential tax treatment was available to us through June 2020 with respect to certain products manufactured at our Pinehurst campus. After June 2020, 50% of our income generated from certain products manufactured at our Pinehurst campus will be exempted from tax through June 2025. Such preferential tax treatment is contingent on various factors, including the export of our customers’ products out of Thailand and our agreement not to move our manufacturing facilities out of our current province in Thailand for at least 15 years from the date on which preferential tax treatment was granted. We will lose this favorable tax treatment in Thailand unless we comply with these restrictions, and as a result we may delay or forego certain strategic business decisions due to these tax considerations.
There is also a risk that Thailand or another jurisdiction in which we operate may treat the Cayman Islands Parent as having a permanent establishment in such jurisdiction and subject its income to tax. If we become subject to additional taxes in
58
any jurisdiction or if any jurisdiction begins to treat the Cayman Islands Parent as having a permanent establishment, such tax treatment could materially and adversely affect our business, financial condition and operating results.
Certain of our subsidiaries provide products and services to, and may from time to time undertake certain significant transactions with, us and our other subsidiaries in different jurisdictions. For instance, we have intercompany agreements in place that provide for our California and Singapore subsidiaries to provide administrative services for the Cayman Islands Parent, and the Cayman Islands Parent has entered into manufacturing agreements with our Thai subsidiary. In general, related party transactions and, in particular, related party financing transactions, are subject to close review by tax authorities. Moreover, several jurisdictions in which we operate have tax laws with detailed transfer pricing rules that require all transactions with non-resident related parties to be priced using arm’s length pricing principles and require the existence of contemporaneous documentation to support such pricing. Tax authorities in various jurisdictions could challenge the validity of our related party transfer pricing policies. Such a challenge generally involves a complex area of taxation and a significant degree of judgment by management. If any tax authorities are successful in challenging our financing or transfer pricing policies, our income tax expense may be adversely affected and we could become subject to interest and penalty charges, which may harm our business, financial condition and operating results.
Several governments are considering various tax reform proposals that, if enacted, may contain provisions that could increase our tax expense. Further changes in the tax laws of various jurisdictions could arise as a result of the base erosion and profit shifting (BEPS) project undertaken by the Organisation for Economic Co-operation and Development (OECD), which represents a coalition of member countries and has recommended changes to numerous long-standing tax principles. If implemented by taxing authorities, such changes could have a material adverse effect on our business, financial condition and operating results.
We have incurred and will continue to incur significant increased costs as a result of operating as a public company, and our management will be required to continue to devote substantial time to various compliance initiatives.
The Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, as well as other rules implemented by the SEC and the New York Stock Exchange (“NYSE”), impose various requirements on public companies, including requiring changes in corporate governance practices. These and proposed corporate governance laws and regulations under consideration may further increase our compliance costs. If compliance with these various legal and regulatory requirements diverts our management’s attention from other business concerns, it could have a material adverse effect on our business, financial condition and operating results. The Sarbanes-Oxley Act requires, among other things, that we assess the effectiveness of our internal control over financial reporting annually and disclosure controls and procedures quarterly. While we are able to assert in our Annual Report on Form 10-K that our internal control over financial reporting was effective as of June 25, 2021, we cannot predict the outcome of our testing in future periods. If we are unable to assert in any future reporting periods that our internal control over financial reporting is effective (or if our independent registered public accounting firm is unable to express an opinion on the effectiveness of our internal controls), we could lose investor confidence in the accuracy and completeness of our financial reports, which would have an adverse effect on our share price.
Given the nature and complexity of our business and the fact that some members of our management team are located in Thailand while others are located in the U.S., control deficiencies may periodically occur. For example, following an internal investigation by the audit committee of our board of directors in September 2014 concerning various accounting cut-off issues, we identified certain significant deficiencies in our internal control over financial reporting, which have been remediated. While we have ongoing measures and procedures to prevent and remedy control deficiencies, if they occur there can be no assurance that we will be successful or that we will be able to prevent material weaknesses or significant deficiencies in our internal control over financial reporting in the future. Moreover, if we identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses in future periods, the market price of our ordinary shares could decline and we could be subject to potential delisting by the NYSE and review by the NYSE, the SEC, or other regulatory authorities, which would require us to expend additional financial and management resources. As a result, our shareholders could lose confidence in our financial reporting, which would harm our business and the market price of our ordinary shares.
If we are unable to meet regulatory quality standards applicable to our manufacturing and quality processes for the products we manufacture, our business, financial condition or operating results could be harmed.
As a manufacturer of products for the optics industry, we are required to meet certain certification standards, including the following: ISO9001 for Manufacturing Quality Management Systems; ISO14001 for Environmental Management Systems; TL9000 for Telecommunications Industry Quality Certification; IATF16949 for Automotive Industry Quality Certification; ISO13485 for Medical Devices Industry Quality Certification; AS9100 for Aerospace Industry Quality Certification; NADCAP (National Aerospace and Defense Contractors Accreditation Program) for Quality Assurance throughout the Aerospace and
59
Defense Industries; and OHSAS18001 for Occupational Health and Safety Management Systems. We also maintain compliance with various additional standards imposed by the U.S. Food and Drug Administration (“FDA”) with respect to the manufacture of medical devices.
Additionally, we are required to register with the FDA and other regulatory bodies and are subject to continual review and periodic inspection for compliance with various regulations, including testing, quality control and documentation procedures. We hold the following additional certifications: ANSI ESD S20.20 for facilities and manufacturing process control, in compliance with ESD standard; Transported Asset Protection Association, or TAPA, for Logistic Security Management System; and CSR-DIW for Corporate Social Responsibility in Thailand. In the European Union, we are required to maintain certain ISO certifications in order to sell our precision optical, electro-mechanical and electronic manufacturing services and we must undergo periodic inspections by regulatory bodies to obtain and maintain these certifications. If any regulatory inspection reveals that we are not in compliance with applicable standards, regulators may take action against us, including issuing a warning letter, imposing fines on us, requiring a recall of the products we manufactured for our customers, or closing our manufacturing facilities. If any of these actions were to occur, it could harm our reputation as well as our business, financial condition and operating results.
Failure to comply with applicable environmental laws and regulations could have a material adverse effect on our business, financial condition and operating results.
The sale and manufacturing of products in certain states and countries may subject us to environmental laws and regulations. In addition, rules adopted by the SEC implementing the Dodd- Frank Wall Street Reform and Consumer Protection Act of 2010 impose diligence and disclosure requirements regarding the use of “conflict minerals” mined from the Democratic Republic of Congo and adjoining countries in the products we manufacture for our customers. Compliance with these rules has resulted in additional cost and expense, including for due diligence to determine and verify the sources of any conflict minerals used in the products we manufacture, and may result in additional costs of remediation and other changes to processes or sources of supply as a consequence of such verification activities. These rules may also affect the sourcing and availability of minerals used in the products we manufacture, as there may be only a limited number of suppliers offering “conflict free” metals that can be used in the products we manufacture for our customers.
Although we do not anticipate any material adverse effects based on the nature of our operations and these laws and regulations, we will need to ensure that we and, in some cases, our suppliers comply with applicable laws and regulations. If we fail to timely comply with such laws and regulations, our customers may cease doing business with us, which would have a material adverse effect on our business, financial condition and operating results. In addition, if we were found to be in violation of these laws, we could be subject to governmental fines, liability to our customers and damage to our reputation, which would also have a material adverse effect on our business, financial condition and operating results.
Risks Related to Ownership of Our Ordinary Shares
Our share price may be volatile due to fluctuations in our operating results and other factors, including the activities and operating results of our customers or competitors, any of which could cause our share price to decline.
Our revenues, expenses and results of operations have fluctuated in the past and are likely to do so in the future from quarter-to-quarter and year-to-year due to the risk factors described in this section and elsewhere in this Quarterly Report on Form 10-Q. In addition to market and industry factors, the price and trading volume of our ordinary shares may fluctuate in response to a number of events and factors relating to us, our competitors, our customers and the markets we serve, many of which are beyond our control. Factors such as variations in our total revenues, earnings and cash flow, announcements of new investments or acquisitions, changes in our pricing practices or those of our competitors, commencement or outcome of litigation, sales of ordinary shares by us or our principal shareholders, fluctuations in market prices for our services and general market conditions could cause the market price of our ordinary shares to change substantially. Any of these factors may result in large and sudden changes in the volume and price at which our ordinary shares trade. Among other things, volatility and weakness in our share price could mean that investors may not be able to sell their shares at or above the prices they paid. Volatility and weakness could also impair our ability in the future to offer our ordinary shares or convertible securities as a source of additional capital and/or as consideration in the acquisition of other businesses.
Furthermore, the stock markets have experienced extreme price and volume fluctuations that have affected and continue to affect the market prices of equity securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those companies. These broad market and industry fluctuations, as well as general economic, political and market conditions such as recessions, interest rate changes or international currency fluctuations, may cause the market price of our ordinary shares to decline. In the past, companies that have experienced
60
volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously harm our business.
If securities or industry analysts do not publish research or if they publish misleading or unfavorable research about our business, the market price and trading volume of our ordinary shares could decline.
The trading market for our ordinary shares depends in part on the research and reports that securities or industry analysts publish about us or our business. If securities or industry analysts stop covering us, or if too few analysts cover us, the market price of our ordinary shares could be adversely impacted. If one or more of the analysts who covers us downgrades our ordinary shares or publishes misleading or unfavorable research about our business, our market price would likely decline. If one or more of these analysts ceases coverage of us or fails to publish reports on us regularly, demand for our ordinary shares could decrease, which could cause the market price or trading volume of our ordinary shares to decline.
We may become a passive foreign investment company, which could result in adverse U.S. tax consequences to U.S. investors.
Based upon estimates of the value of our assets, which are based in part on the trading price of our ordinary shares, we do not expect to be a passive foreign investment company (“PFIC”) for U.S. federal income tax purposes for the taxable year 2022 or for the foreseeable future. However, despite our expectations, we cannot assure you that we will not become a PFIC for the taxable year 2022 or any future year because our PFIC status is determined at the end of each year and depends on the composition of our income and assets during such year. If we become a PFIC, our U.S. investors will be subject to increased tax liabilities under U.S. tax laws and regulations as well as to burdensome reporting requirements.
Our business could be negatively affected as a result of activist shareholders.
If an activist investor takes an ownership position in our ordinary shares, responding to actions by such activist shareholder could be costly and time-consuming, disrupt our operations and divert the attention of management and our employees. Additionally, perceived uncertainties as to our future direction as a result of shareholder activism or changes to the composition of our board of directors may lead to the perception of a change in the direction of our business or other instability, which may be exploited by our competitors, cause concern to our current or potential customers, and make it more difficult to attract and retain qualified personnel. If customers choose to delay, defer or reduce transactions with us or do business with our competitors instead of us because of any such issues, then our business, financial condition and operating results would be adversely affected. In addition, our share price could experience periods of increased volatility as a result of shareholder activism.
Certain provisions in our constitutional documents may discourage our acquisition by a third party, which could limit your opportunity to sell shares at a premium.
Our constitutional documents include provisions that could limit the ability of others to acquire control of us, modify our structure or cause us to engage in change-of-control transactions, including, among other things, provisions that:
•establish a classified board of directors;
•prohibit our shareholders from calling meetings or acting by written consent in lieu of a meeting;
•limit the ability of our shareholders to propose actions at duly convened meetings; and
•authorize our board of directors, without action by our shareholders, to issue preferred shares and additional ordinary shares.
These provisions could have the effect of depriving you of an opportunity to sell your ordinary shares at a premium over prevailing market prices by discouraging third parties from seeking to acquire control of us in a tender offer or similar transaction.
Our shareholders may face difficulties in protecting their interests because we are incorporated under Cayman Islands law.
Our corporate affairs are governed by our amended and restated memorandum and articles of association (“MOA”), by the Companies Law (as amended) of the Cayman Islands and the common law of the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under the laws of the Cayman Islands are not as clearly
61
established under statutes or judicial precedent as in jurisdictions in the U.S. Therefore, you may have more difficulty in protecting your interests than would shareholders of a corporation incorporated in a jurisdiction in the U.S., due to the comparatively less developed nature of Cayman Islands law in this area.
The Companies Law permits mergers and consolidations between Cayman Islands companies and between Cayman Islands companies and non-Cayman Islands companies. Dissenting shareholders have the right to be paid the fair value of their shares (which, if not agreed between the parties, will be determined by the Cayman Islands court) if they follow the required procedures, subject to certain exceptions. Court approval is not required for a merger or consolidation which is effected in compliance with these statutory procedures.
In addition, there are statutory provisions that facilitate the reconstruction and amalgamation of companies, provided that the arrangement is approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting convened for that purpose. The convening of the meeting and subsequently the arrangement must be sanctioned by the Grand Court of the Cayman Islands. A dissenting shareholder has the right to express to the court the view that the transaction ought not to be approved.
When a takeover offer is made and accepted by holders of 90.0% of the shares within four months, the offeror may, within a two-month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands but is unlikely to succeed unless there is evidence of fraud, bad faith or collusion.
If the arrangement and reconstruction is thus approved, the dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be available to dissenting shareholders of a corporation incorporated in a jurisdiction in the U.S., providing rights to receive payment in cash for the judicially determined value of the shares. This may make it more difficult for you to assess the value of any consideration you may receive in a merger or consolidation or to require that the offeror give you additional consideration if you believe the consideration offered is insufficient.
Shareholders of Cayman Islands exempted companies have no general rights under Cayman Islands law to inspect corporate records and accounts or to obtain copies of lists of shareholders. Our directors have discretion under our MOA to determine whether or not, and under what conditions, our corporate records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it more difficult for you to obtain the information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders in connection with a proxy contest.
Subject to limited exceptions, under Cayman Islands law, a minority shareholder may not bring a derivative action against the board of directors.
Certain judgments obtained against us by our shareholders may not be enforceable.
The Cayman Islands Parent is a Cayman Islands exempted company and substantially all of our assets are located outside of the U.S. Given our domicile and the location of our assets, it may be difficult to enforce in U.S. courts judgments obtained against us in U.S. courts based on the civil liability provisions of the U.S. federal securities laws. In addition, there is uncertainty as to whether the courts of the Cayman Islands, Thailand or the PRC would recognize or enforce judgments of U.S. courts against us predicated upon the civil liability provisions of the securities laws of the U.S. or any state. In particular, a judgment in a U.S. court would not be recognized and accepted by Thai courts without a re-trial or examination of the merits of the case. In addition, there is uncertainty as to whether such Cayman Islands, Thai or PRC courts would be competent to hear original actions brought in the Cayman Islands, Thailand or the PRC against us predicated upon the securities laws of the U.S. or any state.
General Risks
Energy price volatility may negatively impact our business, financial condition and operating results.
We, along with our suppliers and customers, rely on various energy sources in our manufacturing and transportation activities. Energy prices have been subject to increases and general volatility caused by market fluctuations, supply and demand, currency fluctuation, production and transportation disruption, world events and government regulations. While we are currently experiencing lower energy prices, a significant increase is possible, which could increase our raw material and transportation costs. In addition, increased transportation costs of our suppliers and customers could be passed along to us. We
62
may not be able to increase our prices to adequately offset these increased costs, and any increase in our prices may reduce our future customer orders, which could harm our business, financial condition and operating results.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Sales of Unregistered Securities
Not applicable.
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
The following table summarizes share repurchase activity for the three months ended March 25, 2022:
| Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased As Part of Publicly Announced Program (1) | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Program (1) | |||||||||||||||||||
| December 25, 2021 – January 21, 2022 | 17,330 | $ | 117.60 | 17,330 | $ | 74,691,275 | |||||||||||||||||
| January 22, 2022 – February 18, 2022 | 159,063 | $ | 102.05 | 159,063 | $ | 58,458,894 | |||||||||||||||||
February 19, 2022 – March 25, 2022 | 60,946 | $ | 97.06 | 60,946 | $ | 52,543,319 | |||||||||||||||||
| Total | 237,339 | 237,339 | |||||||||||||||||||||
(1) On August 18, 2017, we announced that our board of directors had approved a share repurchase program to permit us to repurchase up to $30.0 million worth of our issued and outstanding ordinary shares in the open market in accordance with applicable rules and regulations, including pursuant to pre-set trading plans adopted in accordance with Rule 10b5-1 under the Exchange Act of 1934. In February 2018, May 2019 and August 2020, we announced that our board of directors approved increases of $30.0 million, $50.0 million and $58.5 million, respectively, to the original share repurchase authorization, bringing the aggregate authorization to $168.5 million. The repurchased shares will be held as treasury stock. Our share repurchase program does not have an expiration date. During the three months ended March 25, 2022, repurchases under our share repurchase program were made in accordance with Rule 10b-18 pursuant to a pre-set trading plan adopted in accordance with Rule 10b5-1. During the three months ended March 25, 2022, 237,339 shares were repurchased under the program, at an average price per share (excluding other direct costs) of $101.90, for an aggregate purchase price of $24.2 million. As of March 25, 2022, we had a remaining authorization to repurchase up to $52.5 million worth of our ordinary shares.
63
ITEMS 3, 4 and 5 are not applicable and have been omitted.
ITEM 6. EXHIBITS
| Incorporated by reference herein | ||||||||||||||||||||||||||
Exhibit Number | Description | Form | Exhibit No. | Filing Date | ||||||||||||||||||||||
| 10.1 | ||||||||||||||||||||||||||
| 31.1 | ||||||||||||||||||||||||||
| 31.2 | ||||||||||||||||||||||||||
| 32.1 | ||||||||||||||||||||||||||
| 101.INS | Inline XBRL Instance | |||||||||||||||||||||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema | |||||||||||||||||||||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase | |||||||||||||||||||||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase | |||||||||||||||||||||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase | |||||||||||||||||||||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase | |||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||||||||||||||||||||||
64
SIGNATURE
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on May 3, 2022.
| FABRINET | |||||||||||
| By: | /s/ CSABA SVERHA | ||||||||||
| Name: | Csaba Sverha | ||||||||||
| Title: | Executive Vice President, Chief Financial Officer (Principal Financial and Accounting Officer) | ||||||||||
65